Leslie Loveless, CEO and Managing Partner at Slone Partners is featured in a new episode of “Conversations Life Sciences Leaders Aren’t Having,” a podcast hosted by executive coach Jeff Harmon. The conversation was insightful and spirited, touching on topics ranging from the power of partnerships and her obsession with excellence to the challenges of running a virtual company and the joys of raising an adopted child. Click here to listen to the full podcast.

Industry veteran brings more than 25 years of experience in senior leadership roles SOUTH RIDING, VA. – May 29, 2024 – Slone Partners, a nationwide executive search firm for life sciences and healthcare organizations, has announced the placement of Kevin Eastwood as Chief Business Officer at Arpeggio Biosciences, a preclinical therapeutics company whose technology targets transcriptional dysregulation in disease. Eastwood has more than 25 years of experience in senior leadership roles at innovative pharmaceutical and therapeutics companies across the nation. Most recently he served as Executive Vice President, Corporate Development at Plexium, Inc., where he helped secure a $35M series A-2…

Industry veteran brings expertise in oncology and immuno-oncology and a strong track record of advancing programs through clinical development SOUTH RIDING, VA. – May 14, 2024 – Slone Partners, a nationwide executive search firm for life sciences and healthcare organizations, has announced the placement of Dr. Eugene P. Kennedy, M.D, F.A.C.S. as Chief Medical Officer at Carisma Therapeutics Inc. (“Carisma”), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies. Dr. Kennedy brings more than 15 years of clinical and industry experience to Carisma, including cross-functional leadership driving clinical development and regulatory strategies for oncology and immuno-oncology focused organizations….

Slone Partners, a nationwide executive search firm for life sciences, healthcare, and nonprofit and social impact organizations, has announced the placement of Chris A. Raanes as Chief Executive Officer (CEO) at Magnetic Insight, the global leader in magnetic particle imaging (MPI). Raanes has more than 20 years of experience in the medical device sector, having led companies through pivotal stages of growth and commercialization. Previously, he served as President and CEO at Spire Health, where he supported the commercialization of a wearable sensor for respiratory patients. As President and CEO of ViewRay, he brought the company public on the NASDAQ…

The power of mission-focused nonprofit and social impact organizations to create positive and long-lasting change is undeniable. In the healthcare sector particularly, nonprofit and social impact organizations provide millions of people with critical access to medical care, treatments, and other resources that transform lives. The need for dedicated and talented leaders in this sector is paramount for navigating the many challenges and leveraging the unique opportunities these roles encounter. Visionary leaders drive mission-focused organizations by developing creative and sustainable fundraising and communication strategies and inspiring their teams to push boundaries and exceed their goals, prompting a ripple effect of measurable…

Author: Alicia Montgomery, Chief Talent Officer I had the great pleasure of attending the recent 4th Annual MedTech Color Pitch Competition in Los Angeles, featuring 13 African American and Hispanic company founders pitching their medtech innovations in hopes of securing additional funding. It was such a powerful and engaging half-day of enlightening and inspiring talks by impassioned and radiant visionaries working to bring sorely needed medtech innovation to life. It was surprising and disappointing to learn that African American and Hispanic entrepreneurs receive less than 4% of all venture capital funding. This event was an opportunity to bring attention to…

In the dynamic lineup of SHRM webinars hosted by Slone Partners during the first quarter, attendees were treated to a trio of engaging and enlightening discussions. “Staying the Course: How to Successfully Navigate Your DEI Journey” kicked off the series with a session framed around practical tips and best practices. This webinar didn’t just offer theories; it provided tangible strategies for maintaining a steadfast commitment to diversity, equity, and inclusion (DEI) initiatives, even in the face of shifting priorities and challenges. Participants left feeling empowered and equipped to steer their organizations toward a more inclusive future. Next up was “Candid…

Inclusive leadership is the cornerstone for nurturing a robust and thriving organizational culture, especially in the face of adversity and backlash. It’s about more than policies and initiatives; it’s a mindset and commitment to fostering belonging and empowerment among all individuals. In times of turmoil, inclusive leaders stand firm, advocating for equity and justice while championing diversity in all its forms. They create spaces where every voice is heard, every perspective valued, and every person feels seen and respected. By cultivating empathy, understanding, and a genuine appreciation for the unique experiences of others, inclusive leaders inspire trust and unity, laying…

There are few things more frustrating for companies than investing months in an executive search only to have it fall apart at the end when the prime candidate accepts a counteroffer. Preventing the possibility of successful counteroffers requires intense focus and a strategy designed to maintain the integrity of a fully transparent engagement with the candidate throughout the process. In this blog, we discuss best practices for securing top talent who might otherwise be tempted to accept a counteroffer.  Custom Build the Hiring Team Don’t use a standard template for executive candidate interviews. Custom build each hiring team based…

Eminent thought leaders, changemakers, healthcare professionals, and advocates gathered in San Francisco on Thursday, February 29, for the inaugural Inclusive Leadership Symposium sponsored by California Life Sciences. The daylong event featured presentations and panel discussions centered around maintaining momentum on diversity, equity, and inclusion (DEI) in the life sciences and beyond. Among the participants was Candace Nortey, Slone Partners’ Managing Director of DEI. “With all the backlash on DEI programs in colleges, Board rooms, and political circles, it was great to be a part of an event that brought together such an amazing group of business leaders, allies, and champions…

Managing Director of Diversity, Equity, and Inclusion (DEI) Candace Nortey was recently featured in an exclusive article published by Authority Magazine. Nortey was interviewed on the topic of building inclusive communities, in which she shared her evolving career journey from the classroom to DEI consulting, and on the transformative impacts of diversity and inclusion. “Through deliberate efforts to bridge our divides and foster connections, we cultivate communities that embrace and celebrate differences, recognizing them as strengths that contribute to a more cohesive and resilient whole. By leveraging these strategies alongside others, organizations can make tangible progress toward establishing and maintaining…

Slone Partners CEO and Managing Partner Leslie Loveless was recently featured in an exclusive article published by Authority Magazine. Loveless was interviewed on the topic of the power of authentic women’s leadership, in which she discussed her career path and the successful leadership tactics she has learned along the way. “Working in life sciences, you must be resilient because the market is not steady one quarter to the next. There are serious ups and downs and it’s extremely challenging to predict what’s going to happen next. Because of that, as a leader you need to remain calm and focused, inspiring…

Accomplished and seasoned leader brings more than 17 years of nonprofit experience to new role SOUTH RIDING, VA. – February 1, 2024 – Slone Partners, a nationwide executive search firm for life sciences, healthcare, and cybersecurity organizations, has announced the placement of Dan Latore as Chief Executive Officer (CEO) at Red Door Community, a New York City-based nonprofit organization dedicated to creating a welcoming community of FREE cancer support to bring knowledge, hope, and empowerment to anyone and everyone impacted by cancer. Latore is an accomplished and seasoned nonprofit leader who spent the past 17 years at The Skin Cancer…

An interviewing experience can be stressful for everyone involved. The onus is on the candidate to impress the company with their industry knowledge, communication skills, capacity to think on their feet, and personality. On the flip side, the onus is on the company to demonstrate that they are professional, prepared, and value the candidate’s time. It can be challenging for a company to design an interview process that is truly equitable and bias-free and build an interview team that is aligned and accurately represents the myriad interests of the organization. In this blog, we will explore the ingredients necessary to…

Creating a truly diverse, equitable, and inclusive (DEI) workplace has myriad benefits for organizations in all sectors, but achieving it requires diligence, patience, and persistence. Multiple common barriers must be overcome in the process. These barriers include unconscious biases, fear of the unknown, and the mistaken belief that hiring diverse candidates is enough to check the box on DEI. In this blog, we will explore how to overcome these hurdles and create a workplace culture where everyone feels an authentic sense of belonging.  Unconscious Biases One of the most significant barriers to creating a diverse and inclusive workplace is…

Senior Leaders Bridget Burke and Kate Portand Promoted to SVP & Practice Leaders SOUTH RIDING, VA. – January 18, 2024 – Slone Partners, a nationwide executive search firm for life sciences, healthcare, and cybersecurity organizations, is expanding its footprint in the private equity, healthcare, and nonprofit executive search markets with the promotion of two senior leaders. Bridget Burke, who previously served as the company’s Chief Business Officer, has been named Senior Vice President & Practice Leader, Healthcare, Nonprofits & Social Impact, and Kate Portand has been elevated to Senior Vice President & Practice Leader, Private Equity. The promotions reflect Slone Partners’…

Keeping your highest performers engaged is crucial to the success of any company. That is certainly the case in life sciences, healthcare, and cybersecurity with the competition for talent as intense as ever. However, some organizations simply assume that their best and brightest are always engaged with their work simply because they are the highest performers. The truth is many high performers can become disengaged from their company due to a variety of reasons, including a stagnant work environment, lack of resources, or not feeling valued. Therefore, it is incumbent on companies and their leaders to understand how to keep…

Proven business leader brings more than 30 years of operational and strategic experience SOUTH RIDING, VA. – January 16, 2024 – Slone Partners, a nationwide executive search firm for life sciences, healthcare, and cybersecurity organizations, has announced the placement of Gregory C. Critchfield as Co-Chief Executive Officer (CEO) at EarlyDiagnostics (EarlyDx), the leading company in world-class liquid biopsy methylome detection of early cancer. Critchfield is a proven business leader with more than 30 years of operational and strategic experience in several diagnostic enterprises. As a Board member, former Chairman, and CEO, he led Sera Prognostics from its early financing stages in…

With top talent in life sciences, healthcare, and cybersecurity in such high demand, more and more companies are developing strategies to attract diverse candidates to their organizations. There are many business reasons why diversity recruiting is becoming a high priority for both small and large enterprises. Research shows that the most diverse enterprises are the most innovative, with 19% higher innovation revenues and 9% higher EBIT margins on average. Inclusive teams make better decisions as much as 87% of the time. Decisions made and executed by diverse teams delivered 60% better results. So, what are the techniques companies can deploy…

SVP, VPs, and COO Named Partners as Company Propels to Next Level of Executive Search SOUTH RIDING, VA. – January 9, 2024 – Slone Partners, a nationwide executive search firm for life sciences, healthcare, and cybersecurity organizations, has announced promotions for Senior Vice President (SVP) Kim Wilson, Vice Presidents (VPs) Kim Feitosa, Jennifer Lemasters, and Sona Stroud, and Chief Operating Officer (COO) Chrystie Chapman, all of whom are becoming Partners in the firm. With her promotion to SVP, Executive Search, and Partner, Kim Wilson will continue drawing on her more than 20 years of experience in the healthcare and life…

A healthy, inclusive culture that creates psychological safety, allowing employees to bring their authentic selves to work, is a key to unlocking the potential of a workforce. By forming, supporting, and funding Employee Resource Groups (ERGs), employers send the important message that they value diversity, equity, and inclusion (DEI) and want to leverage DEI to develop an inclusive workplace. An ERG is a voluntary, employee-led group that represents a particular demographic or shared interest within a company. ERGs help employees connect with and support one another, providing organizations with a range of significant short- and long-term benefits. In this blog,…

With the competition for high-level talent as intense as ever, organizations and their leaders are seeking every edge to attract qualified candidates for their important executive positions. Research shows that today’s professionals want to work for organizations with thriving, dynamic, and healthy workplace cultures. Such cultures place a high value on inclusivity, where all employees feel a strong sense of belonging and are empowered to succeed. But creating and sustaining an inclusive culture isn’t easy. It doesn’t happen by accident, but rather through intentional actions where leadership takes ownership. In this post, we will explore how leaders can create and…

As organizations seek to create a more diverse and inclusive workforce, they will need to learn and leverage new strategies to attract candidates for roles and industries for which they have historically not been recruited. Companies in all sectors understand the business benefits of diversity; the challenge is to make it happen. In this blog post, we will outline several strategies for attracting diverse pools of candidates for important positions in the life sciences, healthcare, and cybersecurity industries.  Partner with new and different organizations. By forming partnerships with community and nationwide organizations that provide professional development and job opportunities…

In a recent collaborative venture in San Diego, Slone Partners and California Life Sciences (CLS) assembled a dynamic group of human resources, talent acquisition, and diversity, equity, and inclusion (DEI) champions for insightful discussions and brainstorming on the topic of building positive and inclusive workplace cultures while navigating evolving priorities. Navigating Shifting Priorities Three years after many organizations made initial pledges to enhance DEI, some have made minimal progress toward their goals. The interruption in momentum is influenced by a variety of factors. Building a Toolbox for Success A primary focus of the workshop was to equip participants with a…

Developing a high-level job description that companies can use to attract a robust and diverse pool of qualified candidates may seem like a relatively straightforward task, but it requires a thoughtful, deliberate, and team-oriented approach to get it right.  A well-crafted job description tells a compelling story – about the position, the company, and its unique and important mission. Slone Partners provides support to its client partners to ensure that positions are represented in ways that are attractive, substantive, and inclusive, but also free from unnecessarily overwhelming and non-essential details. The goal is to pique the interest of qualified…

Dozens of life sciences professionals gathered in New York on October 11 for the ‘National Coming Out Day Executive Leadership Panel,’ co-sponsored by Slone Partners and Syndax Pharmaceuticals. The event was an opportunity for industry leaders to share their experiences and insights on LGBTQ+ inclusion in the workplace. National Coming Out Day is observed on October 11 each year to raise awareness about and support for the LGBTQ+ community. It is a day for individuals who identify as lesbian, gay, bisexual, transgender, queer, or any other non-heteronormative sexual orientation or gender identity to share their stories with friends, family, colleagues,…

A 2021 study found that more than 80 percent of organizations were taking steps to enhance diversity, equity, and inclusion (DEI). It is encouraging to see companies putting greater emphasis on their social responsibility, realizing that DEI is an important part of their long-term business strategy. Unfortunately, this progress is now threatened by the near-term inclination for organizations to slash budgets while the economy remains unsettled. The incongruity between short-term and long-term objectives should give companies pause when they determine the value of their DEI initiatives, particularly considering that research shows that inclusive teams make better decisions as much as…

Organizations of all sizes recognize the value of building a diverse workforce and fostering an inclusive culture where everyone can perform to their highest potential. It makes sense from both a social and business perspective. Diversity recruiting is one of the essential strategies used to achieve these goals. In this blog, we will define diversity recruiting and its importance for growing organizations in the highly competitive healthcare, life sciences, and cybersecurity industries.  What is diversity recruiting? Diversity recruiting is a broad term that refers to attracting, recruiting, and hiring individuals from historically underrepresented communities. A diversity recruitment strategy defines goals, accountabilities,…

Extensive research affirms the societal and economic benefits of diversity, equity, and inclusion (DEI) in the workplace. DEI is a vital component of an organization’s success because it helps foster a culture of respect and inclusivity which can lead to enhanced teamwork, increased morale and productivity, better decision-making, and higher profits. In this article, we discuss why DEI is crucial in the workplace and how organizations can create a culture that promotes and sustains DEI. Promotes Creativity and Innovation One of the primary benefits of DEI is that it promotes creativity and innovation in the workplace. By definition, a diverse…

Trio brings extraordinary business and scientific experience to the Fusion Board SOUTH RIDING, VA. – October 31, 2023 – Slone Partners, a nationwide executive search firm for life sciences, healthcare, and cybersecurity organizations, has announced the placements of Jeremy Bender, Ph.D., MBA, Teresa Bitetti, MBA, and David Meek as members of the Board of Directors at Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals as precision medicines for the treatment of cancer. Dr. Bender currently serves as Chief Executive Officer (CEO) of Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company focused on pediatric cancer. Previously, he served as Vice President…

Over the past decade, diversity, equity, and inclusion (DEI) have become increasingly important priorities for companies competing for talent and market share, with even greater emphasis in recent years. Creating a diverse and inclusive workplace encourages employees to bring their authentic selves to work, feel valued, and produce better results. Unfortunately, while many companies understand the importance of DEI, they often fail to translate this comprehension into action. This article highlights the meaning of DEI, why these concepts matter, and how they foster a sense of inclusion and belonging in the workplace.

Insights from CISO veteran Gary Hayslip Are you selling your cybersecurity SaaS (software as a service) to CISOs?  Respected longtime CISO Gary Hayslip, who has more than 20 years of experience leading and managing security programs, teams, and projects in various sectors, offers some helpful tips in a recent interview with Slone Partners Cybersecurity. Gary has a sustained record of building excellent security teams across all industries regardless of regulations and size. He is loyal to companies, a strong Partner to executive teams, a collaborator across organizations, and is always looking for ways to help companies grow. His perspectives will…

Approximately 40 top cybersecurity executives and investors gathered in Boston on October 10 for an engaging Cybersecurity Meet-Up reception and discussion, co-sponsored by Slone Partners Cybersecurity and Glasswing Ventures. Slone Partners Cybersecurity President Mike Mosunic and Glasswing Ventures Founder and Managing Partner Rick Grinnell led a lively discussion about recruiting trends in the Boston cybersecurity ecosystem and the ways in which generative artificial intelligence (AI) could disrupt the cybersecurity industry in both positive and negative ways over both the short- and long-term. Event attendees included executives and investors from several Boston-area companies including 1011 Ventures, .406 Ventures, Allure Security, authentiAI,…

DEI Strategies’ workshops and events will be made available to thousands of HR professionals October 10, 2023 – Diversity, Equity, and Inclusion (DEI) Strategies by Slone Partners has received accreditation as a recertification provider by the Society for Human Resources Management (SHRM). As an authorized provider, workshops, events, and other programs delivered by DEI Strategies by Slone Partners will be made available to thousands of human resources (HR) professionals who are required to earn professional development credits (PDCs) to maintain their credentials. Slone Partners’ extensive line of DEI services and programs includes strategic planning, education and training, diversity recruiting, and…

Non-profit organizations are constantly seeking ways to improve operations, build new partnerships, and increase their impact on the community. Their important missions help improve the lives of millions of people by steering money and other needed resources into communities and causes where private and government dollars aren’t enough. One of the most critical factors for their success is having the right team in place, which includes experienced, talented, and dedicated senior-level professionals. These leaders are in high demand and recruiting them can be a challenge for many non-profits. In this blog, we will explore the reasons why non-profits sometimes struggle…

We are certainly seeing some volatility in the life sciences market right now, but several sectors are red-hot. Artificial Intelligence (AI), for one, is huge – both in healthcare and the life sciences. It is impacting how clinical trials are designed and which patients are chosen to participate in clinical trials. It is impacting the drug discovery process, how drugs are developed, the speed at which they are developed, and the costs involved. Another area where we are seeing tremendous growth is digital health. The development of newer and better wearables capitalizing on non-invasive solutions is treating and healing a…

Slone Partners Cybersecurity delivers dynamic cybersecurity leadership for companies of all sizes, from small and medium-sized enterprises to Fortune 2000, in all industries, as well as executive leadership for investor-backed cybersecurity companies. With the scale and scope of cyber threats expanding daily, we understand the urgency for organizations to lock down their digital perimeter with exceptional leadership that aligns mission with action. It’s not enough to outsource cybersecurity when the business risks are so high. Those risks are mitigated by visionary in-house leaders with the capacity and tenacity to execute an immediate cyber defense strategy. Our relationships with Private Equity…

Industry veteran will lead the company’s next stage of growth and development September 14, 2023 – Slone Partners, a nationwide executive search firm for life sciences, healthcare, and cybersecurity organizations, has announced the placement of Cynthia Pussinen as Chief Executive Officer (CEO) and a member of the Board of Directors at Sernova Corporation, a clinical-stage company and leader in cell therapeutics. Pussinen’s expertise spans the drug development continuum from research through commercialization. She has led the development, licensure, commercialization, and/or subsequent delivery to patients of more than 15 new medical therapies for patients globally, including Obizur® (Antihemophilic Factor (Recombinant), Porcine…

New CMO brings more than 20 years of experience in complex organizational settings  SOUTH RIDING, VA. – August 31, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, today announced the successful placement of Christophe Arbet-Engels, MD, PhD, as Chief Medical Officer (CMO) at X4 Pharmaceuticals, Inc., a biopharmaceutical company developing novel small molecule therapeutics to benefit patients with diseases of the immune system. Arbet-Engels previously served as CMO at several life science companies, including Neurogastrx, Millendo Therapeutics, and Poxel Pharmaceuticals, where he provided research and development leadership, advancing multiple candidates from pre-clinical…

The COVID-19 pandemic reinforced the critical importance of company culture. Physically separated companies had to create virtual cultures to help bring people together and bolster the connections and networks that define great organizations. Employees were no longer running into each other in the lunchroom or grabbing drinks after work. All those physical interactions that build camaraderie went away. As a result, companies had to, in some sense, reinvent their culture via Zoom and the other technologies that we were all suddenly very dependent upon. It was a painful transition, but it was also a learning experience for a lot of…

2023 has brought many changes to the life sciences industry. Perhaps the most significant trend that we’re seeing relates to the flexible work environment. Whereas few companies offered hybrid work options pre-pandemic, most do today and that gets back to employee expectations. Many of them learned during the pandemic that they could be just as productive working from home as from the office, and they save time and money not having to commute. Those companies that don’t offer flexible work options are at risk of losing or not attracting some very talented people who don’t necessarily want to travel to…

Designation provides company with a range of new business and partnership opportunities  SOUTH RIDING, VA. – August 22, 2023 –Slone Partners, a nationwide executive search firm for life sciences, biotechnology, healthcare and cybersecurity companies, has been designated as a Certified LGBT Business Enterprise™ (LGBTBE®) by the National LGBT Chamber of Commerce (NGLCC), providing the company with a wide range of exciting new business and partnership opportunities. “This designation is a significant milestone for Slone Partners, one that underscores the focus and dedication of our team in enhancing diversity, equity, and inclusion in our workplace and throughout our industry,” said Adam…

New director brings more than 30 years of experience as a senior finance business leader  SOUTH RIDING, VA. – August 10, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Robert McMahon as a member of the Board of Directors at OraSure Technologies, Inc., a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services. McMahon has more than 30 years of experience as a senior finance business leader and currently serves as Senior Vice President and Chief Financial Officer (CFO) for…

With an increasing number of organizations reaping the benefits derived from different perspectives, cultural backgrounds, and personal experiences represented by their workforces, many companies are stepping up efforts to seek out more diverse leaders to enhance their Boards of Directors. With that objective in mind, Slone Partners is supporting an initiative by our client Johnson & Johnson Innovation (JJI) to recruit highly qualified diverse business leaders for its visionary Board Fellows, a select community of diverse potential future Board members. Slone Partners’ premier search teams leverage their extensive networks and long-standing relationships with accomplished executives and leading companies in the…

The risks posed by nefarious cybercriminals continue to escalate across almost every sector, making it necessary for organizations to enhance their efforts to build out their cybersecurity teams as quickly and efficiently as they can. However, finding the right cybersecurity specialists can be a daunting task as millions of open positions remain unfilled and companies are scrambling to find the talent they need to protect their cloud-based operations, data, people, and customers. The cybersecurity talent shortage is only making a bad situation worse, with more than two-thirds of organizations reporting that the cyber risks they face are increasing because they don’t have the requisite number of…

The research is clear – Employee Resource Groups (ERGs) and the valuable networks they create are tremendously helpful for building a sense of community and shared purpose for diverse workers, including LGBTQ+ employees. With the objective of sowing cross-pollination between LGBTQ+ ERGs at different biotech companies in the Boston region, Slone Partners co-sponsored along with The Engine and Entrada Therapeutics, the first ever OUTbio ERG Summit, on May 17 in Cambridge. Introductory remarks were delivered by Joe Vogel, OUTbio Vice President and Director of Clinical Operations at Intellia Therapeutics, who said the event brought to life his long-time dream of creating more substantive connections between Boston-area ERGs. The session was co-moderated by Candace…

2023 will be the year of digital health and AI-driven drug discovery and development. Researchers on the front lines of drug discovery and development are using computer vision, machine learning, and AI to a greater extent than ever to support drug discovery and clinical decision-making. This confluence of technologies is allowing clinicians, whether located in an extensive medical center in a large city or in a small practice in a more rural area, to support their patients locally through new and different tech platforms that are add-ons to the current standard of care. Treatment pathways and diagnoses can therefore be…

As companies continue to evolve technologically and more dependent on digital data storage and third-party access, threats from cybercriminals are becoming even more sophisticated and dangerous. Malicious actors are stepping up their attacks on organizations and their cloud-based systems, causing substantial financial losses, compromising sensitive information, and damaging reputations. One of the primary solutions to this escalating issue lies in talent – having a sufficient team of skilled cybersecurity professionals who can navigate the complex digital landscape and strengthen an organization’s defenses. Although sourcing these experts is challenging, there are undeniable reasons why companies must pursue this approach. Here are…

The demand is high for almost every role in the C-suite as well as for Board members, particularly in those cases in which the company is seeking to diversify its Board. Functional areas that are most in demand right now are regulatory affairs, data sciences, clinical development, and business development. Business development executives are very much in demand, including Chief Business Officers and VPs of Business Development. There are very practical reasons for this. Biotech and other life sciences companies understand that their runway to get a product to market is a long one. It takes years to move a…

New company leader brings more than 20 years of experience in top healthcare and medtech roles SOUTH RIDING, VA. – May 18, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Bret Christensen as President, Chief Executive Officer (CEO), and member of the Board of Directors at DermTech, a leader in precision dermatology enabled by a non-invasive skin genomics platform. Christensen comes to DermTech after spending six years as Chief Commercial Officer at Insulet, where he oversaw sales growth from approximately $367 million to $1.1 billion. From August…

The landscape has been changing over the past six to nine months. The headlines have been reporting layoffs in biotech and elsewhere in the life sciences and tech industries as the IPO market has started to slow down, so one might assume this means it is becoming much easier to recruit industry executives now. However, that’s NOT the case. Remember that 2020-22 were booming years in the life sciences, powered by the almost insatiable quest to discover diagnostic tools, treatments, and vaccines to mitigate the impacts of the COVID-19 pandemic, and were further fueled by an incredible amount of investor…

New position reflects company’s commitment to enhancing its impact in the healthcare market SOUTH RIDING, VA. – May 09, 2023 –Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced that Kate Portland has been named Vice President of Client Partnerships. In her new role, Portland will focus on developing and fostering new and existing client relationships to enhance the company’s impact in the nation’s investment firms, healthcare, and life sciences companies. Kate will also develop and lead executive searches for C-suite placements along with placing investment team members for private equity and venture…

Designation reflects company’s commitment to collaboration, innovation, and quality service SOUTH RIDING, VA. – May 3, 2023 – Slone Partners, a nationwide executive search firm for life sciences and healthcare companies, has been named to the list of Top 10 Executive Search Firms 2023 by Manage HR Magazine. The annual list of companies is selected by a panel of experts and members of Manage HR Magazine’s editorial board to recognize and promote entrepreneurship. “We are glad to feature Slone Partners as one of the Top 10 Executive Search Firms 2023. Having established itself as an industry leader for more than two…

When Adam Slone founded Slone Partners in 2000, he did so with a simple vision – to create a company that stood out from the crowd by delivering high-quality professional customer service in the thriving and often demanding industry of executive search. Through his many network connections, Adam was attuned to the ways in which his new company would serve a growing need for talented life sciences and healthcare industry executives in a quickly evolving and competitive marketplace. Adam was the company in its earliest days, but as the business blossomed, so did the need to grow the firm. In…

New Chair brings decades of success to global health technology company SOUTH RIDING, VA. – March 15, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of John Russell as Executive Chairman at Ultromics, a global pioneering health technology company focused on reducing the global burden of heart failure. Russell is a well-respected leader in the medical device and diagnostic sectors of healthcare with over 30 years of experience. Prior to joining Ultromics, Russell served as the CEO and Board Member of Cardiva Medical, Inc. where he expanded the company’s commercialization…

Talented executive brings more than 25 years of experience in the life sciences and technology markets SOUTH RIDING, VA. – March 14, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Paul Scagnetti as Chief Executive Officer (CEO) at ONI, the biotechnology company broadly enabling the ability to observe single molecules in living cells with its desktop Nanoimager microscopy platform. As CEO, Scagnetti will be responsible for driving the company’s future growth and expanding its reach to new customers and markets. He will also build on ONI’s vision to enable…

As a startup company, it is important to carefully consider who you bring on to your leadership team. While some executives may be better suited for larger, more established organizations, others will excel when given the opportunity to help build a company from the ground up. When building your leadership team, you will want to seek out individuals who are passionate about your company and its mission and have the drive and determination to help make your startup a success. With the right leaders in place, your startup will be well on its way to achieving its long-term goals. The…

Expanded line reflects Slone Partners’ focus on delivering the most diverse and qualified Board members for amazing organizations SOUTH RIDING, VA. – March 9, 2023 – Slone Partners, a nationwide executive search firm for life sciences and healthcare companies, has announced that it will expand its line of executive Board placement services to serve more companies in life sciences, healthcare, cybersecurity, and beyond. The service line is designed to identify and source diverse and robust pools of Board candidates, and partner with companies in the interviewing, selection, and onboarding processes. The executive recruitment teams at Slone Partners work closely with their client…

New position reflects company’s commitment to long-term business planning and growth   SOUTH RIDING, VA. – February 21, 2023 –Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced that Bridget K. Burke has been named Chief Business Officer, a new position that reflects the company’s commitment to long-term business planning and growth. In her new role, Burke will serve as an important part of the Slone Partners leadership team and will be responsible for leading, developing, and managing client development opportunities that result in active search engagements and client partnerships. Before joining Slone Partners,…

Key industry veterans will bolster the company’s talented leadership team SOUTH RIDING, VA. – February 9, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Edward Moler, PhD as Vice President of Data Science and Gayathri Swaminath, PhD, MBA as Senior Vice President of Discovery at Juvena Therapeutics, a biotechnology company scaling a computational platform to map the therapeutic potential of secreted proteins. Gayathri Swaminath, PhD, MBA brings more than 17 years of preclinical and translational research and drug development experience. Her leadership and extensive drug development experience at Amgen,…

Retaining high-performing talent is critical to the success of any business, but it can be particularly challenging within the life sciences and healthcare industries which are expanding rapidly as private equity and venture capital dollars continue to flow into the sector. With the competition for top talent fierce, companies must devise strategies that will keep their best employees motivated and engaged. Here are a few ideas on how to accomplish that. Create a Culture of Appreciation One of the most effective ways to retain high-performing talent is to create a culture of appreciation within your organization. Make sure you recognize…

Talented new executive brings 20 years of regulatory experience to the leading global provider of easy-to-use diagnostic solutions SOUTH RIDING, VA. – January 19, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Amy Levin as Vice President of Regulatory Affairs at Mainz Biomed, a biomedical company that develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. In her new role, Levin will be charged with guiding the implementation and regulatory, clinical trial, and quality initiatives that are related to in vitro diagnostics. She will also contribute to key…

Respected biopharmaceutical executive brings experience, passion, and vision to new role SOUTH RIDING, VA. – January 13, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Paul K. Wotton, Ph.D., as Chair of the Board of Directors at Kytopen, an MIT startup biotechnology company leading advancements in novel high-throughput cellular and genome engineering platforms. An experienced CEO, Board Member, inventor, and serial entrepreneur, Dr. Wotton was recently named a “Top 100 Innovation CEO” by World Biz Magazine and won the Ernst & Young Entrepreneur of the Year Regional (NJ)…

Firm serves the cybersecurity talent needs of companies in all business verticals and health systems SOUTH RIDING, VA. – January 6, 2023 – Slone Partners, one of the nation’s leading life sciences and healthcare executive search firms, is pleased to announce the launch of Slone Partners Cybersecurity, a national talent recruitment firm that delivers diverse commercial, operational, and technical cybersecurity specialists and leaders for companies in all business verticals and health systems. The firm is a successor to Wolf Hill Group, which was founded as a joint venture with Slone Partners in 2019. Adam Slone, founder of Slone Partners, will continue…

Leslie Loveless discusses the importance of internal promotion to meet the life sciences executive talent crunch SOUTH RIDING, VA. – December 13, 2022 – There is a talent crunch in the life sciences, particularly in the C-suite, so companies must be innovative in their recruiting approaches. Leslie Loveless, the CEO of Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, shares her perspectives on cutting-edge executive recruiting strategies in a new interview with Pharmaceutical Executive. “It’s about building the bench and making sure that every single time you need to hire someone for leadership, you don’t…

The changes brought about by the COVID-19 pandemic have altered the dynamics of the U.S. workforce and workplace, significantly impacting the ways organizations think about acquiring and keeping talent. The life sciences and healthcare sectors are certainly feeling those impacts as companies scramble to secure talented leaders who will keep them moving forward in a very competitive market. Four trends in particular are evident in the life sciences and healthcare sectors right now: 1. People shortage With the labor market so tight, there are fewer qualified candidates available to fill important leadership roles. That is causing a significant challenge for…

Thomas Schlumpberger is the new CEO and member of the Board of Directors at Nanomix, a leader in mobile, affordable point-of-care (POC) diagnostics. With more than 20 years of experience in the life sciences industry, Dr. Schlumpberger came to Nanomix after serving for 18 months as CEO of Pictor Limited, an international in-vitro diagnostics company focused on infectious disease management. Prior to that, he served in various leadership roles at Anixa Biosciences, Inivata Limited, Singulex, Annai Systems, and Epocal, among other companies. He also serves on the Board of Directors of DxEconomix, which provides healthcare systems and diagnostic companies with…

New CBO brings more than 25 years of pharmaceutical business development experience SOUTH RIDING, VA. – October 20, 2022 –Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Patrick Genestin as Chief Business Officer at 1910 Genetics, a biotechnology company integrating artificial intelligence (AI), computation, and biological automation to accelerate the design of small molecule and protein therapeutics. Genestin brings more than 25 years of pharmaceutical business development experience in leading collaborations ranging from licensing, co-development, and co-commercialization to mergers and acquisitions. Before joining 1910 Genetics, Genestin served as Vice…

New directors are expected to help guide and support company’s next phase of growth SOUTH RIDING, VA. – October 19, 2022 –Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Jason Myers, Ph.D. and Carol Berry to the Board of Directors of InterVenn Biosciences, a clinical technology company leveraging glycoproteomics to transform the future of healthcare. Myers brings to the board more than 20 years of industry and research experience in commercializing innovative genomic tools and diagnostics. He currently serves as CEO of Sequencing Health, an electronic detection platform capable…

As Senior Vice President for Business Development at Precision for Medicine, Jesus ‘Jay’ Lezcano plays an important role helping pharmaceutical and life sciences clients innovate, develop, and commercialize the next generation of medical products. A respected clinical research veteran with a focus on strategic initiatives in the laboratory and biospecimen arena, Lezcano has more than 20 years of experience in business development and sales at various organizations of all sizes – from startups to multibillion dollar enterprises. Lezcano is a Las Vegas native, a child of immigrants, and learned English as a second language. He earned two bachelor’s degrees at…

New CEO brings more than 30 years of medical technology leadership to new role SOUTH RIDING, VA. – August 26, 2022 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Doug Lawrence as Chief Executive Officer (CEO) at Hygieia, a leading digital therapeutics company for insulin therapy, where he will be responsible for leading operations, development, and global growth of the company and its d-Nav® Insulin Management Program. Lawrence brings three decades of medical technology leadership to his new role at Hygieia, including significant experience introducing products to market, restructuring…

New position reflects company’s commitment to expand its healthcare practice SOUTH RIDING, VA. – August 18, 2022 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced that Melissa Hurst has been named Practice Leader for Healthcare. With her extensive background in healthcare executive search, Hurst will focus on expanding the company’s client base with hospitals, health systems, and academic centers. She will also retain her current title of Vice President of Executive Search in which she owns and leads executive level searches with a direct team of consultants whom she manages and mentors….

Prestigious accreditation allows company to offer high-quality HRCI certified continuing education & training SOUTH RIDING, VA. – August 16, 2022 – Diversity, Equity, and Inclusion (DEI) Strategies by Slone Partners has received Approved Provider (AP) accreditation from the HR Certification Institute® (HRCI®). As an AP, DEI Strategies at Slone Partners will offer quality public continuing education events/training and private engagements that are pre-approved based on aligning with HRCI’s Exam Content Outlines. The events meeting those outlines will be made available to thousands of global HRCI-certified professionals who must earn recertification credits to maintain their credentials. Slone Partners’ extensive line of DEI…

New CFO Brings More Than 25 Years of Strategic Leadership Experience SOUTH RIDING, VA. – August 8, 2022 –Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Michael Shaffer as Chief Financial Officer (CFO) at Renovo Solutions, a leading healthcare technology management company that recently received a growth equity investment from Water Street Healthcare Partners. Shaffer is an accomplished executive with strategic, operational, and financial leadership at the corporate, investor, and advisory levels for both public and private equity-backed businesses. Most recently he served as Principal, Portfolio Operations at New…

New CEO will also serve on POC Diagnostics Company’s Board of Directors SOUTH RIDING, VA. – August 1, 2022 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Thomas Schlumpberger as Chief Executive Officer (CEO) and member of the Board of Directors at Nanomix, a leader in mobile, affordable, point-of-care (POC) diagnostics. Schlumpberger is a recognized expert in POC diagnostics and a seasoned senior executive with more than 20 years in the life sciences industry. In his most recent role, as CEO of Pictor Limited, he revamped the company’s product…

New CEO will also serve on biotechnology research company’s Board of Directors SOUTH RIDING, VA. – July 28, 2022 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of George Cardoza as Chief Executive Officer (CEO) and as member of the Board of Directors at AccuraGen, a biotechnology research company that has pioneered the development of liquid biopsy technology to facilitate more personalized cancer treatment. Cardoza joins AccuraGen following a 12-year tenure at NeoGenomics Laboratories where he served as Chief Financial Officer (CFO) from 2009-2018; President, Pharma Services Division from 2018-2021;…

New CFO brings a wealth of financial and investment experience across healthcare and the life sciences SOUTH RIDING, VA. – July 12, 2022 –Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Edward Fan as Chief Financial Officer (CFO) at Clear Labs, the leader in fully automated, next-generation sequencing (NGS) for turnkey genomic surveillance and diagnostics. Fan joins Clear Labs following a distinguished career in healthcare investment banking at J.P. Morgan, where he advised life sciences tools and diagnostics companies on IPOs, M&A, and other financial activities, and Lazard, where…

The tremendous influx of venture capital in the life sciences is affording new and greater opportunities for the most talented C-suite executives. In a recent article published by PharmaVoice, Slone Partners CEO Leslie Loveless offered sage advice to those leaders in the pharmaceutical industry who are thinking hard about their career options. “With Slone Partners’ focus on building executive teams for startup or early stage life science and healthcare companies, Loveless has had a front row seat to the recent bustle of activity in biotech, and how it’s impacted executive salaries and other hiring trends,” the author wrote. “Typically, Slone…

Byline: Adam Slone In 2020, following the George Floyd murder, our leadership team at Slone Partners experienced an ah-ha moment when we realized that we were part of the problem by unintentionally participating in systemic racism. Although at the time, we had an amazing company with amazing people, we only had one person of color on our team. Sadly, while I was aware of systemic racism and the harms that it causes, the issue didn’t resonate personally with me because I strongly support diversity in my own life. But then I watched this video, and everything changed. That video made…

The issue of health equity in America is gaining attention as more people realize its extraordinary potential to improve lives, enhance the nation’s economy, and further our collective goals of achieving greater diversity, equity, and inclusion in our country. The stark differences that people experience as they grow up manifest in myriad ways, but perhaps none more starkly than in the disparate healthcare access and outcomes that occur in our society. The COVID-19 pandemic is just the latest example. A recent study published by JAMA found that “Black, Hispanic, and Asian people have substantially higher rates of infection, hospitalization, and…

New CFO brings more than 15 years of experience in financial leadership roles SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Richard B. Bartram as Chief Financial Officer (CFO) at MBX Biosciences, a clinical stage biopharmaceutical company developing peptide therapeutics with a focus on the treatment of endocrine disorders. Bartram is an accomplished and experienced financial executive with an extensive understanding of the capital markets and a wide variety of experience in private transactions, initial public offerings, follow-on equity offerings, debt offerings, and other financial…

Finding & securing top talent is no easy task. It requires a deep understanding of the company culture and an expertise in assessing the skills, leadership style, and cultural fit of candidates. At the executive level, this is even more important as the new hire will have an impact on the culture and the strategic decisions of the company. In order to find the right talent and greatly improve the success rate of the search, many companies engage an executive recruitment firm. A contract between a search firm and a client falls into one of two categories: a retained search…

With a vast background in both the non-profit and health and fitness sectors, Illyasha Peete is the former Executive Director of Racial and Social Equity at California Life Sciences (CLS). She came to CLS after serving as Director of Diversity, Consulting, and Training for the Center for Excellence in Nonprofits, where she previously worked as Senior Leadership Development Specialist. Peete also has experience in real estate where she held a multi-million-dollar portfolio and continues to serve as a self-employed fitness expert. Earlier in her career, she served as Program Manager for Stanford Health Care – Valley Care. In this position,…

It’s neither easy nor inexpensive for hospitals and health systems to maintain staffing as we emerge from the COVID-19 pandemic and enter into a “new normal.” Severe nursing shortages are making headlines across the country – from California to Massachusetts, and most areas in between. With the system so severely strained, the focus turns to health systems recruiting strategies that will help relieve the pressure on administrators, physicians, and staffers who have been pushed to the limit for the past two years. Addressing the Shortage The New York Times recently reported on the huge pay incentives and immigration fast tracks…

Byline: Slone Partners Collective wisdom can be a blessing or a curse. The collection of perspectives of like-minded people will likely form a very narrow arc, while the collection of perspectives from a group of people with varied backgrounds, ethnicities, and experiences is likely to glean a wide range of thoughts, ideas, and opinions. As Susan Treacy of EnergyBBDO argues in a recent article in Fast Company, “creativity undoubtedly is a team sport. And the more thoughtfully the team is cast, the more original the thinking will be.” And what is true for teams in general is certainly true for…

New CTO brings more than a decade of experience in senior-level recruiting and talent development to her role SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced that Alicia Montgomery has been named Chief Talent Officer (CTO). As CTO, Montgomery is responsible for building out internal systems and programs to support onboarding and the ongoing training, development, and growth of the executive search team. She will also support executive and leadership recruiting engagements through direct interactions with clients to ensure an exceptional experience on every search assignment. Montgomery brings…

Leslie Loveless argues that expansive searches are the ‘new normal’ SOUTH RIDING, VA. – Leslie Loveless, the CEO of Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, presents a unique insider’s perspective on the ‘war for talent’ in the life sciences in a commentary article published March 1 by Life Science Leader. “There is a talent war in the life sciences. The industry is booming with record amounts of venture capital flowing in, and there simply aren’t enough qualified executives to fill all the open positions,” Loveless writes. “This phenomenon is unprecedented in my experience…

New CFO brings more than 20 years of experience in life sciences leadership roles SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Brian Hogan as Chief Financial Officer (CFO) at InterVenn Biosciences, a California-based biotechnology company that utilizes a proprietary high-throughput glycoproteomic interrogation platform using artificial intelligence and mass spectrometry for next-gen precision medicine. Hogan brings more than 20 years of finance and leadership experience in public and private companies to InterVenn. Prior to joining the company, Brian was the CFO at Clear Labs. His…

Byline: Leslie Loveless The past two years have brought much-needed attention to the social, political, and racial inequities that have plagued our country and have inspired new efforts to address them. Fortunately, our nation is now engaged in deep and substantive conversations about how to build a more equitable society and I’m happy to report that we are beginning to see signs of progress toward greater diversity, equity, and inclusion (DEI) in the life sciences. It is exciting to witness our industry become more inclusive, but there is more work to be done. According to one study released this past…

Recruiting talented biopharma leaders in today’s super-charged life sciences economy is no easy task. Venture capital dollars continue to pour into the sector, fueling expansion and incubating cutting-edge startups. At the same time, however, the talent shortage in the industry is reaching unprecedented levels and the “Great Resignation” is only making matters more complicated as millions of people are quitting their jobs after reevaluating their work lives during the pandemic. Biopharma recruitment is more challenging than ever amid these new realities. Overcoming these challenges over the long term will require systemic changes that will take time. Over the short term,…

In today’s dynamic and fast-moving life sciences industry, the competition for top talent is extraordinarily intense. Biotech recruitment is an illustrative example. The sector is booming all around the country, but particularly in the hottest hubs of Boston/Cambridge, the San Francisco Bay Area, New York/New Jersey/Philly, Maryland/Virginia/Washington D.C., Research Triangle Park, and San Diego, where companies are scrambling to attract the most talented, driven, and passionate leaders for their organizations. Biotech recruitment brings its own set of unique challenges because the sector is growing so rapidly, venture capital is flowing faster than ever, and premier talent most always have their…

Life sciences ecosystems are created and nurtured in myriad ways. Some are quintessentially organic, having emerged through the synergistic commingling of research institutions, innovative and entrepreneurial people, and the capital funding needed to seed new companies. Others evolve through careful and intentional planning and operation with a combination of innovative business acumen and public support. In the booming life sciences hubs of Boston, New York, Philadelphia, and the Research Triangle in North Carolina, I see elements of all of these factors at play as these markets continue to thrive. Home to biotech giants such as Biogen and Genzyme, Boston/Cambridge is…

New executive brings 25+ years of experience building and leading commercial teams SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Jonathan Birchall as Chief Commercial Officer at PhaseBio Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases. Birchall has more than 25 years of experience in the biopharmaceutical industry where he has built and led commercial teams in the United States and the United Kingdom. He joins PhaseBio after 12 years at Genentech where he most recently served as Vice…

New board member brings more than 20 years of experience in progressive leadership roles SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of Nathalie Gerschtein Keraudy, President of the Consumer Products Division of L’Oréal, on the Board of Directors at DermTech, a leading genomics company in dermatology. Gerschtein Keraudy has more than 20 years of experience at L’Oréal in progressive leadership roles across Europe, Asia, and America. In her current role as president of the largest division in L’Oréal Group’s top subsidiary, Gerschtein Keraudy is responsible…

New CTO brings 20+ years of experience taking genomic-based technologies to market SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Nigel Beard Ph.D. as Chief Technology Officer (CTO) at Encodia, a rapidly growing platform company that is developing a new generation of protein analysis tools based on single-molecule protein sequencing. Beard succeeds Kevin Gunderson, a company co-founder who crafted and led Encodia’s earliest research efforts. Beard has an accomplished track record in the life sciences, most recently serving as CTO and Senior Vice President (SVP)…

Healthcare firms seeking to fill important leadership positions will often elicit the services of premiere healthcare executive recruiters to conduct their searches. It makes sense for myriad reasons, particularly in this extremely competitive marketplace where talent is at a premium as the most experienced and talented executives are often pursued by several companies at any one time. Premiere healthcare executive recruiters have the established networks, personal relationships, and battle-tested policies and practices in place to move quickly to identify and screen potential candidates, build robust and diverse candidate pools, assist in the selection of finalists, and participate in offer negotiations…

Experienced corporate leader brings unique insights to company’s executive team SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of Scott Gleason as Senior Vice President Investor Relations and Corporate Communications at OraSure Technologies, a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services. Gleason possesses a range of corporate leadership experience in business development and strategic communications across industries. Most recently he served as Senior Vice President of Investor Relations and Corporate Strategy for Myriad Genetics, a leading specialty…

Executive recruiters provide a suite of extremely valuable services for businesses and organizations that need to secure the most talented leaders in a very competitive marketplace. The essential role played by executive recruiters was magnified during the COVID-19 pandemic when operations went virtual. Fortunately, Slone Partners has been an all-virtual company for more than 20 years and was able to quickly pivot to the ‘new normal’ and counsel their client partners who had little or no experience with virtual hiring. As the pandemic wanes and operations begin normalizing again, the opportunities for executive recruiters will become even more exciting. Hunt…

I might be a bit biased, but I’ve always thought Slone Partners is an amazing place to work. So, it was particularly gratifying to learn that the Washington Post agrees when it named our firm among the nation’s Top Workplaces 2021. I’m elated to share this honor with such eminent companies and non-profits as AARP, Capital One, Carfax, CGI, and Fannie Mae, and it is a testament to our phenomenal team that has worked so hard over the years to build a diverse, supportive, and inclusive workplace culture. Culture has always been the glue that binds us at Slone Partners….

Respected executive brings more than 20 years of financial experience to the precision diagnostics company SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of Nipun Soni, CFA, CPA, as the Chief Financial Officer (CFO) at BillionToOne, Inc., the precision diagnostics company. Soni is a seasoned and respected finance executive with more than 20 years of broad financial experience spanning across high-growth public companies in the technology and healthcare sectors. Most recently, while serving as the Senior Vice President of Finance at Guardant Health, Soni raised more…

Authors write that companies are becoming more deliberate about their DEI policies SOUTH RIDING, VA. – A year after the tragic death of George Floyd sparked a renewed push for greater racial and social justice in this country, Slone Partners CEO Leslie Loveless and Candace Nortey, the company’s Executive Director of Diversity, Equity, and Inclusion (DEI), are citing “signs of progress” in the effort to achieve DEI in the life sciences. In a commentary article published last week by the California Business Journal, Loveless and Nortey write that, “In the life sciences, we have historically struggled with building a diverse…

Experienced diversity specialist will lead CLS’s new Racial & Social Equity (RSE) Initiative SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of Illyasha Peete as Executive Director of Racial and Social Equity at California Life Sciences (CLS). In her new position, Peete leads collective strategy and implementation along with developing metrics for measuring the success of CLS’s recently-created Racial & Social Equity (RSE) Initiative. Peete comes to CLS with a wide range of leadership, training, and coaching experience. Previously she served as Director of Diversity and…

Selection reflects firm’s commitment to a diverse, inclusive, and supportive culture SOUTH RIDING, VA. – Slone Partners, a nationwide life sciences executive recruiting firm, is celebrating the honor of being named among the nation’s Top Workplaces 2021 by The Washington Post. The company joins other highly-respected companies selected to the prestigious list. The Top Workplaces selections are based solely on employee feedback gathered through a third-party survey administered by employee engagement technology partner Energage, LLC. The anonymous survey uniquely measures 15 important culture drivers that are critical to the success of any organization: including alignment, execution, and connection, to name…

New board members bring more than 45 years of combined pharmaceutical industry experience SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placements of Stacy R. Lindborg and Christine Pellizzari on the Board of Directors at Celsion Corporation, a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines. Dr. Lindborg brings to Celsion more than 25 years of pharmaceutical industry experience with a particular focus on R&D, executive management, and strategy. She currently holds the position of Executive Vice President and Global Head of Clinical Research at Brainstorm…

New ED brings more than 25 years of experience in organizational leadership SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of Susan Landis as Executive Director of the Association of Clinical Research Professionals’ (ACRP) Board of Trustees. She will begin serving in her new role effective June 14, 2021. Landis brings to ACRP more than 25 years of experience in organizational leadership, including as Vice President at Quintiles, where she helped build and lead a global clinical research engagement group. Most recently, Landis served for six…

New board member brings more than 20 years of experience in technology, life science, and healthcare industries SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of Siddhartha Kadia on the Board of Directors at IsoPlexis, a biotechnology company specializing in functional single-cell proteomics. Dr. Kadia brings more than 20 years of experience to his Board position, having served in leadership positions in the technology, life sciences, and healthcare industries. He previously served as President of the Life Sciences division at Life Technologies, where he was responsible…

Experienced industry leader will join company executive team SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of Stephana Patton, Ph.D., J.D. as Chief Legal Officer (CLO) at InterVenn Biosciences. Patton brings more than 20 years of legal experience to InterVenn. She most recently served as General Counsel, Corporate Secretary, and Chief Compliance Officer at Eiger Biopharmaceuticals, where she was responsible for all legal and compliance matters. Previously, Patton served as General Counsel, Corporate Secretary, and Chief Compliance Officer at BioTime, Inc., and as Vice President, General…

A highly-respected entrepreneur, researcher, and author, Ali Tamaseb has built on his early experience as a business visionary to become a top venture capitalist in the life science and technology industries. He is a Partner at DCVC, a venture capital firm with more than $2 billion in assets under management investing in deep-tech startups. An Iranian-American, Tamaseb studied biomedical engineering at Imperial College London, and graduated from the SIGM Program at the Stanford University Graduate School of Business. At DCVC, Tamaseb focuses on a broad spectrum of areas ranging from computational health/bio to cybersecurity. In the life science and healthcare…

As founder, president, and CEO of Sterling Marketing Group, Karen Tiber Leland heads a strategic communications company that provides brand guidance and marketing consulting services for CEOs and other top executives across sectors in more than 50 countries. Her specialties include executives, CEOs, and personal branding, thought leadership, leadership development, executive presence, social media, and color strategy. Her clients have included Apple, AT&T, Capital One, Google, Johnson & Johnson, LinkedIn, Sprint, and Twitter. Leland is also a best-selling author, having written ten books that have sold more than 450,000 copies worldwide, the most recent of which is “The Brand Mapping…

Respected industry leader will spearhead company’s small molecule drug discovery portfolio SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of Sotirios Karathanasis, Ph.D. as the new Chief Science Officer (CSO) at Enveda Biosciences. In his new role, Dr. Karathanasis will lead the company’s small molecule drug discovery portfolio and work with Enveda’s preclinical team to advance the company’s lead programs for NASH and Wilson’s disease, among other programs. Karathanasis is former CSO of endocrine and cardiovascular research at Lilly Research Laboratories, and has held several other…

2020 was an extremely challenging year for many American companies due to the COVID-19 pandemic, but many medical device companies actually prospered in response to the heightened demand for critical supplies and equipment. While sales declined in Q1 and Q2, they bounced back substantially during the second half of the year as the economy began to stabilize. And 2021 looks even better. A new report from Master Control posits that “If 2020 was the year of disruption, 2021 will be a year of mastering change.” Those companies that were able to pivot quickly, embrace digitization, and adapt to fluctuating customer…

Prestigious list recognizes the ‘most influential, best-in-class recruiters’ across a range of sectors SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has been recognized among the top 50 healthcare and life science executive search firms by Hunt Scanlon. A respected industry leader in human capital sector news and research, Hunt Scanlon annually recognizes the “most influential, best-in-class recruiters” across a range of sectors. This year’s Top 50 list in the healthcare and life science sectors lauds Slone Partners for its esteemed recruitment expertise and customer service. “The firm has a…

The old aphorism, “time is money,” is just as meaningful today as it was when Benjamin Franklin coined the phrase in 1748. And it is just one of several reasons that life science companies, including those focused in biotechnology, pharma, diagnostics, genomics, clinical services, medical devices, data analytics, and food sciences, hire executive search firms to recruit their executives, top leaders, and Board members. Firms like Slone Partners are structured and resourced specifically to manage this process so that their client partners can focus their time and resources on conducting the important and meaningful work that they specialize in. And…

Experienced industry leader to bring expertise and independent judgment to bear on issues of strategy, performance, and resources for global life science company SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of Mark Capone as a Non-Executive Board Member at Abcam, a global life science company that provides precise tools and solutions to advance scientific research. Capone has a distinguished career in the life sciences and currently serves as CEO of Precision Medicine Advisors, a company he founded in 2020. Until October 2020, he served as…

An accomplished senior pharmaceutical executive and thought leader, Hakan Sakul has a distinguished track record in drug development, companion diagnostics development and commercialization, statistical genetics, human genetics, pharmacogenomics, and translational medicine across therapeutic areas. A Turkish native, Sakul received his B.S. and Master’s Degrees from Ankara University, a PhD from the University of Minnesota, where he was a Rotary Foundation Scholar, and conducted his postdoctoral studies at the University of California, Davis. He is a seasoned people-manager and visionary leader who is passionate about the application of technologies to improve human health and well-being. Sakul has spent 21 years in…

The Newest Cohort Arrives in the Workplace. Make way for Generation Z! Members of the newest cohort of young people are now between the ages of 9 and 22 years old, so the oldest among them are just beginning to enter the workplace. As that happens, those who will be hiring and supporting them along their career paths should prepare to welcome a generation of technologically-savvy, productive, and innovative twenty-somethings who embrace direction, feedback, collaboration, and diversity. Who are they?  Members of Generation Z were born between the years 1997 and 2010. They are primarily the children of Generation X,…

Experienced industry leader will advance breakthrough technology into a commercial platform  SOUTH RIDING, VA. –Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of Phil Paik, Ph.D., as Vice President, Platform Development, at Molecular Assemblies, Inc. In his new role, Dr. Paik’s deep expertise in microfluidics and product development will be applied in advancing Molecular Assemblies’ breakthrough enzymatic DNA synthesis technology into a commercial platform. Dr. Paik has more than 16 years of experience in technology innovation and platform development. Prior to joining Molecular Assemblies, he served as Associate Director of…

Geist brings operational experience to Quanterix as company scales to support rapid growth SOUTH RIDING VA.– Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of Will Geist as Chief Operating Officer (COO) at Quanterix Corporation. In his new role, Geist will build on Quanterix’ track record of strong execution as the company expands globally and continues to disrupt pharmaceutical development and diagnostics research. Geist brings more than 25 years of experience to Quanterix, most recently serving as Vice President and General Manager for two of Thermo Fisher Scientific’s largest business…

Experienced industry leader will serve as part of company’s global leadership team SOUTH RIDING VA.– Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of John Leite as Chief Business Officer at InterVenn Biosciences. In his new role, Leite will direct all business operations for the company as part of its global leadership team. Over the past six years, Leite served as Vice President of Oncology, Market Development & Product Marketing for the oncology business unit at Illumina. Prior to joining Illumina, Leite was Vice President of Commercial Strategy and Market…

Experienced industry leader will direct company’s global regulatory strategy SOUTH RIDING VA.– Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of Kevin B. Johnson, Ph.D., MBA, as Senior Vice President of Regulatory Affairs at Inozyme Pharma. In his new role, Johnson is responsible for leading Inozyme’s global regulatory strategy. Johnson brings to Inozyme more than 25 years of experience in developing and implementing global regulatory and clinical development strategies for rare diseases across entire product development lifecycles from preclinical through clinical development and ultimately to product approval for a variety…

Slone Partners, the executive search firm that birthed the program, recently hired Indianapolis area educator Candace Nortey to lead a program that is expected to go national this year.

“By attracting more young people of color into the field and then supporting them along the career path with mentorship and development, we can build a new paradigm,” write Leslie Loveless and Candace Nortey of Slone Partners.

Pharmaceutical recruiters face myriad challenges in the COVID-19 era. With researchers and drug makers working around the clock to develop new vaccines, therapeutics, and diagnostics aligned with Operation Warp Speed, visionary and inspired leadership is absolutely essential to guide companies forward as they negotiate unchartered waters. In general, the industry is stronger than ever. Sector employment continues to rise and venture capital funding for investments in biotechnology, pharmaceuticals, drug discovery and development, and disease diagnosis hit a record $17.8 billion for the year ending Q2 2020, according to the most recent CBRE US Life Sciences Report. Companies like Johnson &…

Experienced industry leader to direct clinical and regulatory SOUTH RIDING VA.– Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of Mike Spigarelli MD, PhD, MBA as Chief Medical Officer (CMO) at Lumen Bioscience. As CMO, Dr. Spigarelli will help advance Lumen Bio’s impressive clinical pipeline. Dr. Spigarelli brings more than 30 years of experience in clinical product development, including trial design, implementation, data analysis, and oversight to his new role. He is also an experienced practitioner in medical research and development, scientific research, and clinical leadership and education. Spigarelli most…

Many of the life-altering advances that we are seeing today in healthcare, biopharma, and diagnostics reflect the tremendous innovations occurring in big data and precision medicine. The landscape is changing rapidly and the pace of change is accelerating exponentially. Such drastic and dynamic change is vastly increasing the potential for new drugs, therapies, individualized treatments, and perhaps even cures for cancer, diabetes, heart disease, and other diseases that kill thousands, if not millions of people every year. One thing is for certain – the intersection of technology, data, science, and healthcare is exploding at a propitious time as the world…

Accomplished expert will oversee quality and compliance and supervise standards across all company operations sites SOUTH RIDING VA.– Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of Kenneth Bonnell as Vice President of Quality and Regulatory Affairs at Aldevron. Bonnell will join the company’s executive team, and in addition to overseeing quality and regulatory compliance, will supervise standards across all of Aldevron’s operations sites. Bonnell is an accomplished quality, operations, and regulatory compliance expert with more than two decades of experience in the biosciences, biotech, and pharmaceutical industries. Most recently,…

New leader to guide company’s strategic growth and expansion initiatives SOUTH RIDING VA.–Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of Dan Monahan as President and Chief Executive Officer of NMS Labs. Mr. Monahan will build upon NMS Labs’ record of success, providing leadership in advancing the organization’s strategic growth and expansion initiatives. Mr. Monahan has extensive experience in various leadership positions during the past nine years with Thermo Fisher Scientific. Most recently, he served as Vice President and General Manager within Unity Lab Services, where he led a $200…

A renowned C-level global branding and growth expert, Mary Stutts has provided strategic counsel in the biotechnology, healthcare, and media industries at Fortune 200 companies for more than 25 years.  Currently the Senior Vice President of Corporate Relations for Sumitovant Biopharma, Stutts has a successful track record leading product marketing communications from early research to blockbuster status for brands like Genentech’s Avastin, Rituxan, Xolair, and Lucentis during a pivotal period of the company’s history when revenues and profit grew five-fold.  She also serves as a member of the Advisory Board of Slone Partners. Growing up as a foster child from…

New leader will guide the company’s strategic growth and expansion SOUTH RIDING VA.–Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of Julianne Averill, CPA, as Chief Financial Officer at Alveo Technologies. Averill will be responsible for leading all financial operations and implementing key business strategies to accelerate Alveo’s growth as the company advances its be.well™ platform, a point-of-care and at-home diagnostic tool currently in development. Averill has more than 18 years of leadership experience in the life sciences, technology, and digital health fields, and has participated in or led more than $2…

Esteemed educator will lead SP’s internal and client-facing D, E, & I efforts SOUTH RIDING VA. – Esteemed educator Candace Nortey has been named Executive Director of Diversity, Equity, and Inclusion at Slone Partners, it was announced today by Slone Partners CEO Leslie Loveless. In this newly created role, Nortey will help expand the firm’s diversity efforts to enhance opportunities for minority candidates, both internally and for the company’s client partners. “Candace Nortey is an extremely accomplished leader in her field and brings a track record of success to Slone Partners at a time when our firm is renewing its…

Experienced corporate consultant augments diverse perspectives on Board SOUTH RIDING VA. – Mary Stutts has been named to the Advisory Board of Slone Partners, it was announced today. Stutts is a renowned C-level global branding and growth expert who has provided strategic counsel in the biotechnology, healthcare, technology, and media industries at Fortune 200 companies including Genentech, Bayer, Bristol Myers Squibb, Kaiser Permanente, UnitedHealth Group, and Comcast NBCUniversal. Mary Stutts is currently the Senior Vice President, Corporate Relations at Sumitovant Biopharma. Growing up as a foster child from the age of five, Stutts in 2004 founded The Center for Excellence…

In this fourth edition of Slone Partners’ new interview series on executive and workplace diversity, we’re delighted to present an exclusive interview with Maria Palasis, Ph.D. Having served in positions of increasing leadership at several successful life science companies throughout her career, Maria Palasis is one of the most accomplished and respected executives in this fiercely competitive field. She earned a Ph.D. in Chemical Engineering from the University of Cincinnati and completed a postdoctoral fellowship in molecular biology at the University of Cincinnati School of Medicine. Dr. Palasis began her career at Boston Scientific Corporation, a medical device company, where…

America faces a watershed moment. The nationwide protests and heartfelt debates prompted by the tragic deaths of several young Black men and women underscore the intrinsic systemic racial injustices that continue to plague our country. Like many people, I have been deeply moved by the level of anguish that is evident in the messages articulated by the protesters, many of whom hold signs reading “I can’t breathe” to underscore the horrendous consequences of George Floyd’s death as well as the suffocating realities of everyday life for many Black Americans. Now is the time for all of us to acknowledge and…

In this third edition of Slone Partners’ new interview series on executive and workplace diversity, we’re delighted to present an exclusive interview with Jacqueline Kosecoff. As one of the most experienced and accomplished leaders in the managed healthcare field, Jacqueline Kosecoff is truly a pioneer in the industry. Having earned her Ph.D. at the University of California, Los Angeles, Kosecoff has served in a variety of important roles at some of the nation’s top health care, diagnostics, and drug development companies. At the beginning of her career, she helped found and lead Private Equity-back companies, including Value Health Sciences and…

In this second edition of Slone Partners’ new interview series on executive and workplace diversity, we’re delighted to present an exclusive interview with Christine Vanderpool. As the CISO of Florida Crystals, the world’s largest sugarcane refiner and collection of retail sugar brands, Christine leads a team that protects the company from technology breaches across the company, throughout supply and distribution chain. Prior, she was the Deputy CISO and Executive Director of Cyber Risk at Kaiser Permanente. Earlier in her career, Christine spent 13 years at global brewer Molson Coors, rising from Application Security Manager to Chief Information Security Officer. Most…

Company recently received Emergency Use Authorization for its molecular point-of-care COVID-19 diagnostic test May 14, 2020 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of Ingo Chakravarty as President and Chief Executive Officer (CEO) of Mesa Biotech. Chakravarty assumes leadership of the company less than two months after it received Emergency Use Authorization (EUA) from the Federal Drug Administration (FDA) to market its 30-minute point-of-care (POC) molecular SARS-CoV-2 test. Chakravarty joins Mesa Biotech with more than 25 years of experience and a proven track record in capital formation and building…

In the new C-19 world, competition for top life sciences jobs will be difficult. Be prepared. Soon-to-be college graduates are understandably nervous as they approach their virtual Commencement Day. The massive economic disruptions caused by the coronavirus outbreak are affecting most every industry, and job seekers will have to be nimble and patient as they enter the job market. In California, the life sciences industry, with more than 3,400 companies employing more than 300,000 people, is working around the clock to develop testing tools, diagnostic equipment, treatments, therapies, and vaccines to accelerate an end to the COVID-19 crisis. And over…

‘Business as usual’ has taken on an entirely new meaning for life sciences companies in the age of COVID-19 as they shift their operations online. Virtual operations encompass almost the entire scope of company functions, from research and development to marketing and sales. Perhaps one of the most challenging elements of this new paradigm is virtual recruitment, hiring, and onboarding of new executives. Identifying a suitable and appropriate pool of candidates for C-level positions has always been a time- and labor-intensive exercise, but moving the process along completely virtually requires extraordinary focus, patience, strategic calculation, and technological capacities. Since the…

One of the most significant events for any business is a high-level executive transition. Yet not all executives turn out to be the right fit for their company. Research by the Corporate Executive Board (CEB) shows that as many as 50-to-70 percent of newly hired or promoted leaders fail within the first 18 months, and the challenges for new leaders is even greater today in the age of COVID-19 and all-remote workforces. The financial cost of losing one of these new leaders can often be enormous, several times the executive’s salary. Worse yet, when indirect costs such as lost business,…

April 14, 2020 – Slone Partners, a nationwide executive search firm for life sciences and diagnostics companies, has announced the placement of Roger D. Klein, M.D., J.D., FCAP, as Chief Medical Officer (CMO) of OmniSeq®. Dr. Klein will support OmniSeq in its continued development of innovative products that help oncologists identify the best precision medicine options for their patients. Dr. Klein joins OmniSeq with nearly 30-years of experience in the medical industry and a distinguished career in molecular pathology. He previously held leadership roles in molecular pathology at Cleveland Clinic, the BloodCenter of Wisconsin and the H. Lee Moffitt Cancer Center….

In this first edition of Slone Partners’ new interview series on life sciences executive and workplace diversity, we’re delighted to present an exclusive interview with Travis McCready. As the former CEO of Massachusetts Life Sciences Center – which has deployed $700 million in investments and workforce programs – Travis sat at the intersection of the state’s thriving life sciences industry, interacting with startups and multinationals and the brilliant people who make progress happen. Yale educated, his remarkable professional journey includes milestones of being a corporate attorney, Director of Community Affairs for Harvard University, Chief of Staff and VP of Programs…

Warfare and other moments of great national urgency often spawn momentous innovations that change our way of life. The current coronavirus outbreak is no exception. All of us are learning by necessity the art and science of ‘social distancing’ in our collective effort to slow the rate of infection. In many states and municipalities bars, restaurants, and nightclubs are closed completely, or at least reducing their intake of customers, and employers are asking and even sometimes requiring their employees to work from home, a phenomenon quite foreign to many organizations and individuals. We at Slone Partners have a lot of…

Coco Brown is the founder, CEO and board member of Athena Alliance, a digital platform dedicated to revolutionizing leadership, from senior management to the boardroom. Founded in 2016, Athena Alliance aims to transform the current boardroom towards a modern composition model. Coco has led the organization to amass a network of over 1000 C-Level women, VCs, and CEOs from over 150 companies, including Walt Disney, Genentech, Viacom, Cisco, Microsoft, Intuit, Autodesk and Alphabet / Google. In the organization’s first three years, Coco and her team have supported 434 interviews of women for board seats and 97 board placements. Beyond board seats, women…

JANUARY 23, 2020 – The impact of new medicines, procedures, data analytics, and other innovations created by companies in biotechnology, diagnostics, therapeutics, laboratory and clinical services during the first two decades of the 21st century have changed the lives of millions of people around the world. And as Slone Partners celebrates its 20th anniversary this year, its evolution as a leader in life sciences executive search closely resembles that of the industry itself. “We have witnessed an incredible myriad of breakthroughs and discoveries in the life sciences during our 20-year history as a company,” said Slone Partners founder Adam Slone….

2020 marks the 20th anniversary of Slone Partners, which is now recognized as a national leader in life sciences, biotech, diagnostics, and healthcare executive recruiting. Company founder Adam Slone recently spoke about his experience starting the company, developing a unique corporate culture, hiring a top-notch leadership team, and his philanthropic efforts devoted to helping young people from underserved communities. Slone Partners: Starting a new business can be scary. What do you recall about the early days of Slone Partners?   Adam Slone: The first couple of months were exhilarating, but also a bit scary. Prior to founding Slone Partners, I served…

With the nation’s economy churning on all cylinders and the labor market stretched thin, many companies are having to work harder than ever to attract and retain the best talent. As CEO for a nationwide life sciences executive recruiting firm, I can attest to the challenges we and our client partners face in attracting the right people for the biggest and most mission-critical positions. There simply isn’t enough top talent to go around, so companies need to separate themselves from the pack to position themselves as “the” place where people want to be. Experienced executives with stellar track records as…

Slone Partners’ quarterly Leadership Series continues with an exclusive interview with Craig Overpeck, CEO of Science and Medicine Group, the leading life sciences market research company in America. Mr. Overpeck’s firm, through scientific community intelligence networks and diverse product offerings allowing them to serve multiple stakeholders, has tripled in size in recent years through organic growth and M&A activity. This activity puts Science and Medicine Group on the unique forefront of offering strategic program viability, product pricing and product positioning support to Fortune 500 companies. Slone Partners is delighted to present our exclusive interview with Craig Overpeck. Slone Partners: Science and Medicine Group…

Dr. Carl June is the Richard W. Vague Professor in Immunotherapy and Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine at University of Pennsylvania. He is one of the world’s leading cancer researchers and was named to the Time 100, the magazine’s annual list of the most influential people in the world. As part of Slone Partners’ ongoing series of interviews with scientific healthcare industry trailblazers in conjunction with Personalized Medicine Coalition, we are delighted to present our exclusive interview with Dr. June. Slone Partners: Our mutual friends at Personalized Medicine Coalition bring together the brightest minds in…

As part of Slone Partners’ 2019 PMC Interview Series, we are delighted to present an exclusive interview with Anne-Marie Martin, Ph.D., SVP and Global Head of Precision Medicine at Novartis Pharmaceuticals, and Board member of Personalized Medicine Coalition. As one of the largest pharma companies in the world, Novartis offers 85 medicines, 26 of which are in oncology; employs 108,000 people comprised of 140 nationalities; and does business in 155 countries, giving both the company and Anne-Marie a unique global perspective.  This ongoing series of healthcare executive discussions is presented in partnership with the Personalized Medicine Coalition 15th Annual Personalized…

Kenna R. Mills Shaw, Ph.D., is the Executive Director of the Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy and Cancer Genomics Laboratory at the University of Texas, which was established at MD Anderson Cancer Center following a $150 million grant from the royal family of the United Arab Emirates. As part of Slone Partners’ ongoing series of interviews with scientific healthcare industry trailblazers in conjunction with Personalized Medicine Coalition, we are delighted to present our exclusive interview with Dr. Shaw. Slone Partners: Geographically, the gift to Texas-based MD Anderson from the royal family came from the other…

Kicking off Slone Partners’ 2019 PMC Interview Series, we are proud to present an exclusive discussion with Mark P. Stevenson, Executive Vice President and Chief Operating Officer at Thermo Fisher Scientific. With approximately 70,000 employees around the globe and more than $24 billion in annual revenues, the company is the world leader in serving science. It enables scientists, laboratories and cutting-edge companies to accelerate life sciences research and deliver medicines faster. Mark’s unique global perspective on the future of precision medicine is illustrated in his thoughtful answers. This ongoing series of healthcare executive discussions is presented in partnership with the Personalized Medicine…

SEPTEMBER 10, 2019 – Slone Partners has announced that it is investing in a joint venture to expand outside of healthcare and into the cybersecurity industry with Wolf Hill Group, LLC, which will focus exclusively on recruitment in cybersecurity. The two companies will work together to bring best practices in executive search to address a talent shortage that is expected to see 3.5 million unfilled cybersecurity positions by 2021”, according to Cybersecurity Ventures. “Wolf Hill Group will leverage the deep experience in executive search that we have developed over the past 20 years in the life sciences and biotech sectors…

GO2 Foundation for Lung Cancer, the Washington DC / San Francisco area—based entity resulting from the April 2019 merger of the Bonnie J. Addario Lung Cancer Foundation (ALCF) and the Lung Cancer Alliance, is America’s largest non-profit devoted exclusively to eradicating lung cancer. A lung cancer survivor herself, co-founder & Chair of the Board Bonnie Addario established the Bonnie J. Addario Lung Cancer Foundation (ALCF) in 2006 and has raised more than $30 million toward the cause. Leveraging her executive leadership skills honed in the petroleum industry, Bonnie has now become an important voice in solving lung cancer, the #1 most…

Maintaining the current momentum in California’s life sciences hinges on industry leaders. Commentary by Leslie Loveless, Special to California Business Journal.   While the trends certainly look good, there are some possible storm clouds on the horizon. The national economy, which has been supercharged over the past 18 months, will eventually simmer, impacting capital flows; threats of trade wars and tariffs are getting markets and investors nervous; regulatory compliance remains challenging, particularly for companies operating internationally; and California’s escalating cost of living continues to serve as a significant factor preventing some companies from locating to the Golden State. So maintaining…

Slone Partners’ quarterly Leadership Series continues with an exclusive interview with David Welch, Ph.D., Director of Science and Technology of The Good Food Institute. The organization works with innovating scientists, forward-thinking investors and food-marketing entrepreneurs to make groundbreaking plant-based and clean meat “good” food a reality. By focusing on 4 key areas, The Good Food Institute provides strategic support to companies; fosters the next generation of innovators; educates institutions & policymakers; and promotes plant-based products. As plant-based lifestyle adoption sweeps America, and the science behind food product development rapidly advances, Slone Partners is delighted to have spoken with Dr. Welch…

The announcement last month by the Baker Administration and the Massachusetts Life Sciences Center (MLSC) that they are providing more than a million dollars for STEM equipment and professional development in five large under-resourced school districts across the state is the latest indication that the need for young, smart, diverse leaders in this industry is bigger than ever. The Commonwealth trails only California in life sciences employment, generating more than $13 billion in total wages. However, there are signals of a growing talent shortage in the industry, and as the sector continues to expand, so too will the challenge of…

Supporting the life sciences community through dynamic live programming that focuses on the people and executives needed to lead, commercialize, and grow life sciences companies. Slone Partners and Bonneville Labs, the provider of shared laboratories, workspaces and services for life science and hard tech companies, produced a live panel discussion with some of the most respected healthcare industry bankers and investors in San Francisco. Life Sciences Springs Ahead marked an opportunity for an insightful conversation about what’s hot and what’s not in healthcare finance following Q1. Moderated by Jon Norris and Barbara Alcaraz Silva, Ph.D. of Silicon Valley Bank, and accompanied…

Dr. Wenstrup brings 25 years of clinical leadership experience in oncology, genetics and pharmacogenomics SAN FRANCISCO – May 15, 2019 –Slone Partners, North America’s leading executive search firm for life sciences and diagnostics companies, announces the placement of Richard Wenstrup, M.D., at Epic Sciences, Inc. as Chief Medical Officer. Dr. Wenstrup leads clinical development, regulatory and medical affairs strategies, and is responsible for advancing the company’s clinical research and product development pipeline. Based at the company’s headquarters in San Diego, California, he reports directly to CEO Lloyd Sanders. Epic Sciences develops novel diagnostics to improve and personalize the treatment and…

This week on Leaders’ Insights, Leslie Loveless of Slone Partners talks to us about her role in recruitment and what keeps her up at night. Leslie Loveless is CEO and head of recruitment at Slone Partners, where she divides her time between developing new client relationships, supporting long-term clients, working on marketing strategies for the firm and aligning the company’s overall business strategy. Prior to joining Slone Partners, Loveless had a successful career in healthcare sales, serving as national sales trainer with Quest Diagnostics and later as director of training and development for AmeriPath. Earlier in her career, she spent…

Executive Search Firm Supports Emerging Life Sciences Community with Resources Focusing on Building Capital Through People SAN FRANCISCO – May 1, 2019 – Slone Partners, North America’s leading executive search firm for life sciences and diagnostics companies, announces a strategic partnership with Bonneville Labs (BVL), the provider of shared laboratories, workspaces and services for life science and hard tech companies. Bonneville Labs offers tenant support from Slone Partners that focuses on the people and executives needed to lead, commercialize, and grow life sciences companies. The partnership is starting at BVL’s state-of-the-art shared laboratory campus in Berkeley, California. Bonneville Labs hosts…

Integral to forging the future of pediatric precision healthcare, this fantastic conference brings genomics leaders, researchers and healthcare industry together to share ideas and attend workshops with a mission of making the littlest patient’s lives better. Our patient-focused executive search firm encourages everyone in precision health, pediatrics and industry to attend this conference and workshops. Learn more below about the daily schedule taking place May 1-3. Already informed? WHAT Rady Children’s Institute for Genomic Medicine’s annual Frontiers in Pediatric Genomic Medicine Conference brings leaders in research, industry and healthcare together to explore advances in translating genomic diagnostics into targeted treatment for…

Commercialization and marketing-focused C-suite executive specializing in oncology brings more than 20 years experience in diagnostics and pharmaceuticals industries  SAN FRANCISCO – April 16, 2019 – Slone Partners, North America’s leading executive search firm for life sciences and diagnostics companies, announces the placement of Lloyd Sanders at Epic Sciences, Inc. as Chief Executive Officer. With headquarters in San Diego, California, Mr. Sanders is responsible for all strategic and business aspects of the oncological diagnostics company. Epic Sciences develops novel diagnostics to improve and personalize the treatment and management of cancer with a mission to extend patient lives. The company’s focus is…

Top executive brings 20 years financial experience in pharma and diagnostics to support Quanterix Corporation’s plans for rapid growth BOSTON – April 12, 2019 – Slone Partners, North America’s leading executive search firm for life sciences and diagnostics companies, announces the placement of Amol Chaubal at Quanterix Corporation as Chief Financial Officer. Responsible for the strategic and tactical financial health of Quanterix as the precision medicine company executes rapid scaling, Mr. Chaubal will report to CEO, President and Chairman Kevin Hrusovsky at the company’s headquarters in Lexington, Massachusetts.  Through differentiated proprietary technologies, Quanterix (NASDAQ: QTRX) digitizes biomarker analysis to advance…

Slone Partners’ quarterly Leadership Series opens 2019 with an exclusive interview with Kevin Hrusovsky, President, Chairman and Chief Executive Officer of Quanterix. Kevin Hrusovsky is an American biotech entrepreneur, engineer, and healthcare visionary who has dedicated his 30-year career to transforming medicine from reactive “sick care” to preventive and personalized healthcare. As President, Chairman and Chief Executive Officer of Quanterix, a technology-driven precision health company which empowers researchers primarily under its Simoa® biomarker detection platforms, Kevin is on the cutting edge of modern scientific healthcare. Slone Partners: Quanterix markets Simoa® – a digital biomarker detection technology utilized in oncology, neurology,…

Executive brings 26 years experience both running clinical research sites and managing them for contract research organizations BOSTON – February 28, 2019 – Slone Partners, North America’s leading executive search firm for life sciences and diagnostics companies, announces the placement of G Paul Evans, PhD, as President and Chief Executive Officer of Velocity Clinical Research. Based at the company’s headquarters in Durham, North Carolina, Dr. Evans will be responsible for setting the strategic vision, scaling teams and research sites, and delivering high-quality study data to clients while growing patient recruitment. Over the past 20 years, Velocity Clinical Research’s numerous clinical…

California’s Groundbreaking Legal Mandate for Women Serving on Boards of Directors of Publicly Traded Companies Goes Into Effect in 2019 The end of 2019 marks California’s deadline for publicly traded companies with headquarters or “principal executive offices” in the state to comply with a new law requiring women have seats on their board of directors.   The progressive bill, named SB-826 and signed into law in Q4 2018 by then-Governor Jerry Brown, is the most dramatic evidence yet that state governments not only take diversity seriously, but that economic well-being is at stake, too. After all, California’s $2.7 trillion GDP is…

This year will likely prove to be a banner year for new and seasoned corporate life sciences executives looking to change jobs in the life sciences. With the industry continuing to benefit from the fast pace of technological advancements, the growing influx of venture capital, and an expanding global marketplace, 2019 will bring greater demand for the top leaders needed to catapult life sciences companies forward. Increasing competition for top life sciences executives across interconnected sectors means that accomplished candidates often attract multiple offers from firms operating in biotech, precision medicine, genomics, and medical diagnostics. It isn’t a simple calculation…

Dr. Czerwiec was most recently Vice President, Global Clinical Development at Otsuka Pharmaceutical Development & Commercialization, Inc., helping to develop kidney disease therapies BOSTON – January 9, 2019 – Slone Partners, North America’s leading executive search firm for life sciences and diagnostics companies, announces the placement of Frank Czerwiec as Chief Medical Officer at Goldfinch Bio, a biotechnology company focused on discovering and developing precision medicines for the treatment of genetically-driven kidney diseases. In this newly created role, he is responsible for leading all aspects of clinical strategy and clinical development, including biostatistics, pharmacokinetics, pharmacometrics, clinical operations, medical affairs and…

As we approach the new year, Slone Partners’ quarterly Leadership Series closes out 2018 with an exclusive interview with Anthony Johnson M.D., Chief Executive Officer of Goldfinch Bio. Singularly focused on discovering and developing precision medicine therapies for kidney disease, Goldfinch Bio, a Third Rock Ventures company, prepares for clinical trials with its new drug GFB-887 to help the over 800 million patients worldwide suffering from kidney disease or failure. Now, Dr. Johnson shares his thoughts on leadership, precision medicine, and the importance of strong networks of support. Slone Partners: Your executive career has included impressive roles at very large…

15-year veteran of Thermo Fisher Scientific is a global business development leader  SAN FRANCISCO – December 5, 2018 – Slone Partners, North America’s leading executive search firm for life sciences and diagnostics companies, announces the placement of Eric Blair at Argonaut Manufacturing Services as Chief Commercial Officer. Now responsible for the development and execution of the company’s commercial activities, alliances, and growth opportunities, Mr. Blair will be based at Argonaut’s headquarters in Carlsbad, California and report to CEO Wayne Woodard. Argonaut Manufacturing Services is a contract manufacturing organization (CMO) dedicated to serving highly innovative companies in the biopharmaceutical and molecular diagnostics…

Mr. Mercer brings over 25 years of exceptional scientific healthcare leadership experience   San Francisco -December 4 – Slone Partners, North America’s leading executive search firm for life sciences and diagnostics companies, announces the placement of Michael Mercer at Karius, Inc. as Chief Commercial Officer. Now responsible for developing, executing, and leading the commercial business strategy, Mr. Mercer will be based at Karius’ headquarters in Redwood City, California and report to CEO Mickey Kertesz Ph.D. Karius is a precision medicine-focused life sciences company transforming infectious disease diagnostics using genomics.  The Karius Test is a quantitative next-generation sequencing test that helps clinicians rapidly…

World-class healthcare executive, former Global Chief Medical Officer of Strategy, Partnerships, and Informatics at healthcare powerhouse Royal Philips, is also a medical doctor, surgeon, and university professor SAN FRANCISCO – Tuesday, November 27, 2018 – Slone Partners, North America’s leading executive search firm for life sciences and diagnostics companies, announces the placement of Roy Smythe, M.D. at SomaLogic, Inc. as Chief Executive Officer. Now responsible for strategically developing, commercializing, scaling, and fund-raising for the company, Dr. Smythe will be based in Boulder, Colorado and report to SomaLogic’s board of directors, including founder Larry Gold, Ph.D. With 200 employees worldwide, SomaLogic is a leader in…

The latest in our series of dynamic live programming Slone Partners produces in major U.S. healthcare hubs addressed the state of scientific healthcare investing, and the coming-of-age of artificial intelligence, machine learning, and Big Data in biopharma Dx, and tools. We proudly partnered with Biocom San Francisco on October 25, 2018 for Insights: Scientific Healthcare Investing 2018, a lively panel discussion that produced a wealth of insights into what’s driving banking and venture capital decision-making in a scientific healthcare environment which increasingly relies upon advanced technology. Over 110 scientific healthcare executives and industry watchers were in attendance for an evening of discussion…

Slone Partners’ 2018 PMC Interview Series concludes with an exclusive, in-depth interview with Bryce Olson, a Global Strategist at Intel Corporation’s Health & Life Sciences Group. Intel isn’t just a chipmaker – it’s deeply committed to technology-driven healthcare innovation. In addition to Intel’s “All In One Day” vision for cancer patients of providing primary sequencing, secondary analysis, then precision medicine implementation in just 24 hours, the company is a leader in optimizing life sciences codes, healthcare analytics, medical reimbursement and patient & doctor education. Mr. Olson, a Stage-4 cancer survivor whose battle and frank humanity has propelled him to national…

Slone Partners’ 2018 PMC Interview Series enters its 4th week with an exclusive, in-depth interview with Colin Hill, the Chairman, CEO and Co-Founder of GNS Healthcare, an innovator in artificial intelligence (AI) applications in personalized medicine. On a mission to “unravel the complexities of human disease” utilizing causal machine learning, GNS Healthcare serves health plan providers, biopharma companies, academic medical centers and research organizations. This ongoing series of healthcare executive discussions is presented in partnership with Personalized Medicine Coalition.  See Colin Hill participate in the panel discussion Automating Actionable: How Artificial Intelligence May Chart a Course for Personalized Medicine November 14th at…

Slone Partners’ 2018 PMC Interview Series continues with an exclusive, in-depth interview with William Dalton Ph.D M.D., the Founder and Executive Chair of M2Gen, a health informatics solutions company. Focused on accelerating the discovery, development and delivery of personalized medicine, M2Gen was founded in 2006 at the Moffitt Cancer Center to operationalize the Total Cancer Care® Protocol, and through its proprietary ORIEN Avatar™ solution, to partner with cancer research centers via The Oncology Research Information Exchange Network (ORIEN). Together, M2Gen works with biopharmaceutical companies to address the most challenging questions in drug development. Dr. Dalton discusses personalized medicine, his leadership tenure as CEO, and the importance…

Slone Partners’ 2018 PMC Interview Series continues with an exclusive, in-depth interview with David P. King, the Chairman and CEO of LabCorp, a leading global life sciences company. Under Mr. King’s leadership, LabCorp’s 60,000 employees have helped LabCorp become the world’s largest healthcare diagnostics company, annually serving 115 million patients, processing 130 million patient specimens, and supporting clinical trial activity in 100 countries. This ongoing series of healthcare executive discussions is presented in partnership with Personalized Medicine Coalition. See David P. King deliver the keynote address for The Lay of the Lab: Exploring the State of the Clinical Laboratory Testing…

Produced in conjunction with Biocom, the October 25, 2018 discussion in South San Francisco explores the capital markets and conditions driving innovative companies forward in Drug Discovery, Services, Tools and Diagnostics. October 17, San Francisco  -Slone Partners, the leading executive search firm for life sciences, diagnostics, and scientific healthcare companies, proudly announces Insights: Scientific Healthcare Investing 2018, a panel discussion event taking place October 25, 2018 in South San Francisco. In conjunction with co-producer Biocom, the association representing the life science industry of California, Slone Partners has assembled six prominent venture capitalists who will explore the financial markets and conditions driving healthcare innovation utilizing artificial intelligence (AI), Machine Learning (ML) and…

Slone Partners’ 2018 PMC Interview Series debuts with an exclusive, in-depth interview of Daniel O’Day, the CEO of Roche Pharmaceuticals. A division of Switzerland’s Roche, Roche Pharmaceuticals is a life sciences powerhouse, treating over 137 million patients in 2017 as the world’s largest biotech company and provider of cancer treatments. Mr. O’Day discusses Roche Pharmaceuticals’ market leadership, motivations for personalized medicine acquisitions, and his executive life living in Switzerland, Japan and Denmark. This ongoing series of healthcare executive discussions is presented in partnership with Personalized Medicine Coalition.  Slone Partners: You’ve been at Roche since 1987. In your opinion, what’s been…

Beginning October 2018, The Leading Healthcare Executive Search Firm Again Partners With Personalized Medicine Coalition To Interview 5 Industry Trailblazers September 25, 2018 – BOSTON – BOSTON – Slone Partners, the leading executive search firm for life sciences, diagnostics and scientific healthcare companies, proudly announces the world-class roster of executives slated to be featured in its 2018 PMC Interview Series. The Q&A sessions, released online beginning October 2018 and into November in collaboration with Personalized Medicine Coalition (PMC), will feature five healthcare industry heavyweights and trailblazers who sit on the cutting edge of the most exciting advancements in modern patient…

Over 60 teenage participants from New York to Boston experienced a two-week, once-in-a-lifetime upstate New York camp, mentored on tennis and leadership September 20, 2018 – BOSTON – Slone Partners, the leading executive search firm for scientific healthcare companies, along with founder Adam Slone, proudly announces the successful completion of the Third Annual Life Serve Youth Foundation (LSYF) Tennis Camp. The August 12th-26th 2-week program is North America’s only sleepaway tennis camp for underserved youth. The 60 participants are primarily inner-city teens living in the New York to Boston corridor. The camper experience at Camp Eagle Hill, 90 miles north of…

In this quarter’s newsletter, we exclusively interview Laurie Halloran, Founder and CEO of her pioneering Halloran Consulting Group, which assists life sciences firms with an array of wisdom, guidance, and problem-solving. An award-winning lecturer and visiting teacher at Ivy League universities, Ms. Halloran’s approachable brand of “Damn Good Consulting” has helped the Boston healthcare community embrace and celebrate diversity of all stripes. Since 1998, your namesake consulting firm, Halloran, has been helping startups and bellwether life science firms navigate a myriad of strategic, commercial, and regulatory obstacles and opportunities they face every day. What’s the most rewarding aspect of your…

The latest in our series of dynamic live programming Slone Partners produces in major U.S. healthcare hubs addressed the essentials of corporate culture. We proudly partnered with Biocom San Francisco July 26, 2018 for INSIGHTS: Culture As A Cornerstone, Bay Area Perspectives, a lively panel discussion which produced a wealth of takeaways for startup, small and midsize healthcare companies. Moderated by Lisa Suennen, Senior Managing Director at GE Ventures and Managing Partner at Venture Valkyrie, LLC, Slone Partners and Biocom were delighted to be joined by four exceptional human resource executives: Kim McEachron, Chief People Officer, Genomic Health Adrienne Seal,…

Former Deloitte Consulting and IQVIA executive joins global biopharmaceutical product and portfolio strategy firm   August 6, 2018 – BOSTON – Slone Partners, North America’s leading executive search firm for life sciences and diagnostics companies, announces the placement of Dr. Paul Harney as President, North America at Prescient Healthcare Group. Dr. Harney will be responsible for delivering Prescient’s North America growth strategy and enhancing client satisfaction. He was also named to Prescient’s Board of Directors.  Founded in 2007, Prescient is a leading biopharmaceutical product and portfolio strategy firm, offering evidence-based decision support for life sciences companies in the areas of commercial…

Successful nationwide search secures former professor and Chairman of the Department of Obstetrics & Gynecology at the University of Tennessee College of Medicine-Chattanooga, who will direct all clinical development activities for The Pregnancy Company™   JUNE 17, 2018- BOSTON – Slone Partners, North America’s leading executive search firm for life sciences, diagnostics and scientific healthcare companies, announces the placement of Dr. Garrett K. Lam at Sera Prognostics, Inc. as Chief Medical Officer. Effective September 8th, 2018, Dr. Lam M.D. FACOG, will be based at the Company’s headquarters in Salt Lake City, Utah overseeing clinical operations personnel and collaborating with research…

How To Activate Board Members and Senior Executives To Build Thriving Cultural Environments For Scientific Healthcare Companies & Beyond As part of Slone Partners’ ongoing series of exclusive interviews with scientific healthcare and human capital trailblazers, we’re delighted to present Sarah Larson, Partner & Chief Human Resource Officer at Third Rock Ventures; Russell Campanello, Executive VP Human Resources & Corporate Communications at iRobot; Sanjiv Patel, Chief Executive Officer at Relay Therapeutics; and Coco Brown, Chief Executive Officer at Athena Alliance. The group collectively participated in Slone Partners’ June programming, a dynamic live panel event in Boston observed by nearly 100…

Distinguished Recognition Marks Almost Two Decades of Growth For The Life Sciences and Diagnostics Industries-Focused Firm With National Presence In All Major U.S. Healthcare Hubs BOSTON, JUNE 2018 – Slone Partners, North America’s leading life sciences and diagnostics industry executive search firm, proudly announces the Company has again been recognized by Hunt Scanlon’s Executive Search Review’s (ESR) Top 50 list of largest, fasting growing executive search firms in the U.S. and Americas.  Hunt Scanlon Media, the premier, widely-referenced executive search industry research and news organization, compiled its list regardless of executive search specialty.  2018 marks the firm’s 17th year of consecutive growth…

At Insights: Culture As A Cornerstone, The Firm Explored How To Activate Board Members and Senior Executives To Build Thriving Cultural Environments For Scientific Healthcare Companies & Beyond BOSTON, JUNE 2018 – Slone Partners, North America’s leading executive search firm for life sciences and diagnostics companies, organized a dynamic panel discussion – Insights: Culture As A Cornerstone – examining the ways, means, and importance of activating board members and senior executives to build thriving cultural environments. As part of its ongoing series of dynamic live programming the Company produces on a quarterly basis in healthcare epicenter markets such as Boston,…

As a preview to Slone Partners upcoming event INSIGHTS: CULTURE AS A CORNERSTONE in Boston June 6, 2018, we asked our moderator and panelists to answer a single question about what shapes their thinking. The goal of creating thriving cultural environments through board and senior management activism is the latest topic which Slone Partners uniquely addresses in its ongoing series of dynamic live programming. These events regularly take place in the most important science and healthcare hubs across North America. To attend Insights: Culture As A Cornerstone June 6th at the Seaport World Trade Center & Hotel, RSVP to LeslieL@slonepartners.com. SARAH…

Former Senior Vice President, Healthcare Investment Banking at Raymond James & Associates, Now Leads OraSure’s Mergers, Acquisitions & Strategic Initiatives  May 01, 2018 – BOSTON – Slone Partners, North America’s leading executive search firm for life sciences and diagnostics companies, announces the placement of David Rappaport at OraSure Technologies as Senior Vice President, Business Development. Mr. Rappaport will be based at the Company’s headquarters in Bethlehem, PA. Publicly-traded OraSure Technologies (NASDAQ: OSUR) develops, manufactures and distributes fourteen distinct oral fluid diagnostics and collection devices, cryosurgical products, and other technologies to detect or diagnose critical medical conditions. These products include the OraQuick® In-Home HIV…

With quickly-changing marketplaces, retained search firms are more often collaborating with high-growth companies to discover fresh, consumer-centric talent. Historically, precision medicine was referred to as personalized medicine – taking highly-tailored, personal approaches from diagnostics to treatments. But the National Institutes of Health (NIH) and the National Research Council (NRC) have now better defined precision medicine as approaching individual patient health from genetic, environmental and lifestyle points of view. Where does that leave personalized medicine companies? In short, the terminology now means patient-first, technology driven, and individual-empowered. Executive search firms strategically retained by the most ambitious personalized medicine companies have become…

For the past 17 years, Slone Partners has excelled in a very specialized search practice; placing executive management and leadership both in North America’s most promising startups and historically successful life sciences, precision medicine and diagnostics companies. We do so exclusively on a retained basis, a business model we deeply believe is particularly advantageous for our clients, with results that bolster our mutual belief. But what are the main differences between contingency placement firms and retained firms like ours? Slone Partners CEO Leslie Loveless sheds light.   What are the main differences between the retained model and the contingency search…

Gynecologic disease bio-analytical solutions company retained Slone Partners to identify exceptional CFO with global distribution experience  Boston, Massachusetts — Slone Partners, North America’s leading executive search firm specializing in the life sciences and diagnostics sectors of healthcare, announces the placement of Bob Beechey at Vermillion, Inc, in the newly-created post of Chief Financial Officer. Mr. Beechey will be stationed at Vermillion’s facility in Trumbull, CT. Educated at the Wharton School of Business at the University of Pennsylvania prior to earning his MBA (with Distinction) from INSEAD, Fontainebleau, France, Mr. Beechey has a proven track record with significant financial leadership roles in…

As part of Slone Partners’ ongoing series of exclusive interviews with healthcare pioneers, we’re delighted to present Harry Glorikian, a global healthcare industry businessman, observer, and writer for over three decades. Well-known in the life sciences, diagnostics, and healthcare IT communities, himself holding four US patents in telecommunications, Mr.Glorikian spoke with Slone Partners to offer his insights into healthcare industry disruption, technology, and future developments.  SLONE PARTNERS: Apple, Amazon, JP Morgan, and Berkshire Hathaway have all announced they’re tackling healthcare directly for the benefit of their employees – a privatization of processes and upending of traditional “market rate” costs. What’s your take…

Big Data, Bioinformatics, & PM Disrupt. Slone Partners Understands. Healthcare has never been more exciting, or fragmented, or more specific, or more complicated. Insurance coverage, betting against illness or treating disease, is arguably the most consequential lightning-rod issue of our times.  How to fix systems and processes, pay for care, and actualizing a healthier nation has a myriad of complications. But promising healthcare startup companies and successful multinationals continue to launch, and dominate, even as one key factor ironically emerges that changes, well, everything: Patients, through technology and fascinating new diagnostic tools, are taking increasing control of their own bodies and…

Slone Partners works closely with Codexis to place MDx expert after nationwide search March 7, 2018, San Francisco, CA — Slone Partners, North America’s preeminent healthcare executive search firm, proudly announces the successful placement of Ms. Shawn Clairmont in the newly-created position of Senior Director of Molecular Diagnostics at Codexis Inc. (NASDAQ: CDXS), a leading protein engineering company. With an exceptional 13 years molecular diagnostics strategic marketing experience, Ms. Clairmont proved uniquely suited to shepherd Codexis’ first commercialization of high-performance enzymes for use in next generation sequencing and polymerase chain reaction (PCR/qPCR) applications. Slone Partners, working closely with Codexis Senior VP Corporate & Strategic Development Michael Aldridge, conducted a nationwide…

Slone Partners Produces Healthcare Funding Trends and Tactics Event at Genentech Hall, Byers Auditorium at UC San Francisco for 70 Investors, Drug Discovery, Dx, and Tools Leaders THURSDAY, FEBRUARY 22, 2018, SAN FRANCISCO – This evening, Slone Partners, North America’s leading healthcare industry executive search firm, organized a dynamic panel discussion – Build an Amazing Diagnostics, Tools or Drug Discovery Company with the Right Financial Partners – revealing deep insights into the challenging funding types, pathways and considerations healthcare startup and growth-stage healthcare firms must strategically navigate. Over 70 healthcare industry investors, drug discovery, Dx and tools leaders were in…

Slone Partners Produces Healthcare Funding Trends and Tactics Event at Genentech Hall, Byers Auditorium at UC San Francisco for 70 Investors, Drug Discovery, Dx, and Tools Leaders THURSDAY, FEBRUARY 22, 2018, SAN FRANCISCO – This evening, Slone Partners, North America’s leading healthcare industry executive search firm, organized a dynamic panel discussion – Build an Amazing Diagnostics, Tools or Drug Discovery Company with the Right Financial Partners – revealing deep insights into the challenging funding types, pathways and considerations healthcare startup and growth-stage healthcare firms must strategically navigate. Over 70 healthcare industry investors, drug discovery, Dx and tools leaders were in…

As part of our ongoing series of interviews with healthcare pioneers, we’re delighted to present Kimberly Popovits, Chairman of the Board, CEO, and President of Genomic Health. Ms. Popovits currently sits on the boards of the California Life Sciences Association (CLSA), the Personalized Medicine Coalition (PMC), the American Clinical Laboratory Association (ACLA), and MyoKardia, a precision medicine firm focusing on cardiovascular disease. In this interview, we discover how audacious thinking, risk-taking, and the quest for once-impossible scientific breakthroughs are positively reshaping the lives of cancer patients. SLONE PARTNERS: Genomic Health is recognized as a trailblazer in molecular diagnostics. When you…

Executive search firm, Slone Partners, announces the placement of Roger Moody as Chief Financial Officer with Clinical Genomics. Moody is a reputable industry expert with a proven track record in leading finance and operations for rapidly growing companies. Clinical Genomics is a leading provider of cancer testing solutions that develops innovative products to improve early detection of colorectal cancer in both the screening and cancer recurrence setting. Founded in 2006, the company now holds a broad intellectual property portfolio including more than 20 patents. In his new role, Moody will direct all strategic and tactical financial operations. His extensive experience…

Slone Partners: How does someone become the President of Clinical Next-Generation Sequencing and Oncology of a $20 billion company like Thermo Fisher? Take us on your personal journey. Dr. Goswami: To keep things in perspective, it’s just one of several divisions in a very large company. I’ve been fortunate enough to be with Thermo Fisher for over 13 1/2 years now, and for me, the whole idea about coming to Thermo Fisher was to be able to learn new skill sets, be exposed to a different industry than I had been part of before, and to really get my hands…

Leading up to the Annual Personalized Medicine Conference hosted in Boston this November, Slone Partners presents its exclusive interview series featuring two industry trailblazers. This special series shares the unique insights of these thought leaders as the field of personalized medicine is increasingly changing the nature of healthcare and offering new treatment perspectives. To set the stage, our first interviewee, Dr. Michael Sherman, discusses the benefits of adopting an outcome-based framework along with the future of coverage and reimbursement for therapeutics and diagnostics. He also addresses health plans enhancement, the potential for payers to drive appropriate adoption of usage, and…

Venerable management consulting firm McKinsey & Company recently released a study, How To Create An Agile Organization, a deep dive into how companies are striving to achieve “the ability to quickly reconfigure strategy, structure, processes,people, and technology toward value-creating and value-protecting opportunities.” But few large companies have been able to become as agile as they need to be; unable to contract their reactions to ever-faster competitive threats, game-changing technologies, unpredictable regulatory changes and fluctuating demands for their products and services. Market forces are rapidly changing, leading these companies to attempt agility or get left behind. Disruption surrounds us. Turning on…

Executive Search Firm Slone Partners Fosters Financial Partners Discussion at LabCentral, Cambridge’s Innovation Launchpad for Life Sciences, Diagnostics, and Biotech Startups Slone Partners, North America’s premier healthcare industry executive search firm, organized a focused panel discussion,Building an Amazing Organization With the Strength of the Right Financial Partners, achieving rare insights into the importance of strategic financing for nascent-stage healthcare firms. The panel participants – Bijan Salehizadeh, MD, Managing Director of Navimed Capital (who acted as moderator); Oded Ben-Joseph PhD, Managing Director of Outcome Capital; Vikas Goyal, Principal of SR One; Sarah Larson, Partner at Third Rock Ventures; and Ryan Sansom,…

Internationally acclaimed oncology expert shares her insights on new targeted cancer therapies   Renowned for her work in cancer research, Dr. Barbara Weber is a seasoned oncology leader with over 25 years of experience in cancer genetics and drug development. In this exclusive interview, she shares her unique involvement in cancer research and drug development and discusses Tango Therapeutics’ distinctive approach to developing targeted therapies. Slone Partners: Dr. Weber, throughout your career you have made it your professional mission to advance the fight against cancer. Over the years, what has been your most fulfilling accomplishment towards this quest? Dr. Weber:…

Leading Diagnostics Executive Search Firm Fills Board of Directors Role for True Health Group Premier national executive search firm, Slone Partners, announces the placement of Patrick Young to the Board of Directors for True Health Group, the parent company of True Health Diagnostics. Founded in 2014, True Health Diagnostics is a leading integrated diagnostics and healthcare services organization specializing in early detection and management of cardiovascular diseases, diabetes, cancer, genetic disorders and a range of metabolic conditions. The company is currently undergoing an important growth phase. True Health recently launched a new platform of hereditary cancer testing, called genTrue. Another True…

And now for a remarkable personal story which departs from our usual blog topics. Slone Partners’ founder Adam Slone was born with Gaucher’s Disease, a rare genetic disorder that enlarges the spleen and can cause bone crisis and fatigue, regularly sidelining him from raucous playgrounds and sports as a child. Proper diagnoses, dedicated physician care, and pharmaceutical therapies throughout his childhood and adolescence finally enabled Adam to explore something he yearned for – physical fitness and the great outdoors. And from the miracles of modern medicine, he discovered the wondrous world of tennis.  Aerobic, balletic and often intense, tennis mastery…

“The potential for diagnostic information to drive decision-making has never been greater or more important. As healthcare becomes more personalized and treatment more targeted we need to be innovative about how we think about what test to do when, how to interpret data for clinicians and patients, and how to pay for this information.” — Caroline Popper, MD, MPH, Founder and President of Popper and Company Click here for the full article

The 9th Annual Next Generation Dx Summit, held in Washington, D.C., will welcome over 1,000 industry experts from across the globe to network and collaborate on issues facing the diagnostics space. Key topics on the agenda include novel immunotherapy biomarkers, cell-free DNA, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, clinical NGS assays, commercialization, reimbursement, prenatal testing, circulating tumor cells, critical care, forensics, digital PCR, microfluidics, and microbiome diagnostics. Offering an impressive curriculum of speakers and timely discussions, the Next Generation Dx Summit has become a must-attend event for Slone Partners and for other leading industry organizations. To assist with selecting…

Seasoned industry expert to lead the organization’s science and technology initiatives National executive search firm, Slone Partners, announces the placement of Linda Robbie, PhD, a well-versed leader with extensive assay development and biomarker expertise, as VP of Scientific Affairs at Cambridge Biomedical. Established in 1997, Cambridge Biomedical is a Boston CRO specializing in bio-analytical assay development and sample testing services. The organization acts as a leading provider of customized assays for small and large molecules, biomarkers, and diagnostics. In her new role, Dr. Robbie will serve as the head of science and innovation and will lead and direct all initiatives related to…

Slone Partners welcomed a panel of premier industry leaders on June 8th to discuss the initiative steered by the executive search firm, “Building Value in Precision Medicine: Can We Overcome the Obstacles?” Michael Pellini, MD, Chairman of the Board of Directors of Foundation Medicine, led an open discussion with expert panelists Troy Cox, CEO of Foundation Medicine, Barbara Weber, MD, Interim CEO at Tango Therapeutics, and Roman Yelensky, PhD, Chief Technology Officer, Gritstone Oncology. The panel reviewed the state of the Precision Medicine arena and shared approaches on developing strategic methods and collaborative partnerships to improve patient outcomes. They addressed…

Held in Chicago, the 53rd edition of the DIA conference themed “Driving Insights to Action” will welcome over 7,000 global life science leaders from the pharmaceutical, biotechnology, and medical device industries. Offering more than 160 sessions, DIA 2017 will cover essential topics including: Big Data/eHealth, Medical Affairs & Scientific Communication, Patient Engagement, Strategic Planning and Executive Partnerships, and more. For another year, Slone Partners, executive search firm specializing in recruiting talent for the life sciences, diagnostics, clinical trials, CRO, therapeutics, healthcare IT, and laboratory testing industries will be in attendance. This conference is a not-to-be-missed opportunity to network with industry professionals,…

Leadership Series Interview with Charles Mathews, Vice President at Boston Healthcare In this exclusive Slone Partners’ interview, senior health care reimbursement consultant, Charles Mathews, shares his views on the industry and overcoming the challenges and obstacles that it faces. He also addresses the development of clinical utility evidence for molecular diagnostics and laboratory tests, offers his perspective on the potential implications of health reform legislation, and provides valuable advice on commercializing new diagnostics products. Slone Partners: Reimbursement has emerged as a big issue for diagnostic innovators. Is there much hope for improvements to the reimbursement environment? Charles Mathews: Reimbursement is really…

“A patient has nothing without an accurate and timely diagnosis. Diagnostics are the glue that holds the healthcare system together. An inaccurate, missed or delayed diagnosis can be the difference between profoundly different outcomes in quality and length of life.” — Mara Aspinall, CEO of Health Catalysts and Board Member of Slone Partners. Click here for the full report: THE DIAGNOSTICS YEAR IN REVIEW 2016

Premier executive search firm Slone Partners is proud to show its ongoing support to the Executive War College as a Corporate Benefactor for this year’s event. Hosted in New Orleans, the Executive War College conference addresses the most current challenges the laboratory medicine industry is facing. Each year, over 700 of the country’s most preeminent pathologists, laboratory administrators and industry executives convene at the Executive War College conference to share insights, discuss market trends, and uncover strategies to key management and reimbursement issues. “With the steady shift from fee-for-service to value-based reimbursement, clinical laboratories in the U.S. face growing pressure…

Distinguished ASC leader, Daniel Brazell, to steer the exponential growth of one of California’s most reputable private surgery centers Executive search firm, Slone Partners, announces the placement of Daniel Brazell, MBA, as Chief Executive Officer with La Peer Health Systems. Brazell is a recognized industry expert with a proven track record in outpatient surgery management, business strategy, and process improvement. Located in Beverly Hills, La Peer Health Systems is a privately held, state-of-the-art surgery center composed of world-renowned surgeons and highly trained nurses. The independent healthcare provider is committed to providing the highest quality of patient care paired with the most…

A fully integrated cultural assessment is key to completing a successful search. When making a new hire, assessing cultural fit will help predict an individual’s performance within an organization. A handful of professionals may have the required skillset and qualifications for the position, but the optimal candidate must be a match for the cultural environment of the company. A number of elements define the organization’s unique culture: work environment, leadership style, way of conducting business, values, processes, pace, and how information and power flows through the hierarchy. Each candidate has a unique personality profile that has to be taken into…

Senior life sciences executive, Mark Harvill, to drive company’s sustained growth Executive search firm, Slone Partners, announces the placement of Mark Harvill as Chief Executive Officer with Avomeen Analytical Services. Harvill is a distinguished life sciences expert with a proven track record in strategic global business development and operations. Avomeen is a leader in a wide range of services related to laboratory testing and analysis for the pharmaceutical, medical device, polymer, cosmetic, consumer products, health & beauty, and manufacturing industries. The company was founded in 2010 by retiring founder Shri Thanedar, Ph.D. High Street Capital of Chicago is the majority…

Premier executive recruitment firm, Slone Partners, is proud to have been named a Top 50 Healthcare & Life Science Search Firm by Hunt Scanlon Media. Hunt Scanlon Media is one of the most respected life science publications in the United States and the most widely referenced global news source in the human capital sector. “It is a great honor for Slone Partners to be part of this distinguished list of leading executive life science search firms. Hunt Scanlon is the media reference when it comes to all that is happening in the market, and to be selected by them alongside…

Venture Partner, Wildcat Venture Partners Venture Partner, Mohr Davidow Ventures Accelerating the Success of Next Generation’s Healthcare Entrepreneurs In this exclusive Slone Partners interview, Dr. Phyllis Whiteley, seasoned venture capitalist and life science consultant, shares her insights on the most promising areas of healthcare technology and exciting breakthroughs entering the market. She also discusses her work at Wildcat Ventures and her passion for mentoring leaders and helping startups reach their full potential. Slone Partners: You have had a varied career in Healthcare, what are you currently doing? Dr. Whiteley: I have spent the last decade working in Venture Capital as…

Slone Partners introduces a new contemporary web platform Premier recruitment firm, Slone Partners, announces the launch of its new web platform featuring a contemporary design, expertly curated content, and improved navigation to better meet the evolving needs of clients and candidates. Slone Partners’ new website includes a responsive web design that provides an optimal user experience across all devices, including smartphones and tablets, as well as rich visuals, concise content, and simplified navigation. “As a leading executive search firm, Slone Partners remains in sync with today’s rapidly changing trends. The recruitment process, and how clients and candidates conduct searches, has…

Matt Posard, a seasoned industry leader, joins GenePeeks to drive the commercialization of breakthrough disease risk analytics. Executive search firm, Slone Partners, announces the placement of Matt Posard, as President and Chief Commercial Officer with GenePeeks. Matt is a veteran life sciences and molecular diagnostics executive with extensive commercialization experience. GenePeeks is a computational genomics company focused on identifying inherited disease risk in future generations. In his new role, Matt will be responsible for leading the commercialization of its products and services as the company enters its next important growth phase. “We are grateful to the talented team at Slone…

Molecular Med Tri-Con, to be held February 19-24, 2017, continues to be one of the largest and most well-attended conferences in Molecular Diagnostics. In 2016, Tri-Con attracted over 3,500 professionals from over 40 countries from the world of Molecular Medicine, specifically in Discovery, Genomics, Diagnostics and Information Technology. San Francisco, still buzzing from January’s JP Morgan Healthcare Conference, is always ready to accept the next round of companies and investors into its hub of innovation. As a long time attendee of Tri-Con, Slone Partners is an active participant, and the leading specialized executive search firm in the diagnostics space. It…

Executive search firm Slone Partners proudly supports the SCOPE Summit for Clinical Ops Executives 2017 in its continued commitment to the advancement of the clinical trials segment. Hosted in Miami, this conference brings together renowned decision makers to discuss current issues related to clinical trial planning and management. As executive talent specialists in the industries central to clinical trials, Slone Partners’ active participation in the summit supports leaders that are mobilizing change in the healthcare arena as they look to hire top talent and grow their organizations. With over 1,200 participants projected for the 2017 event, SCOPE reunites an impressive…

A sea of change is coming to healthcare. An explosion of new technologies for fitness and wellness, chronic disease monitoring, cancer therapy, glucose levels, and even medication compliance, have emerged onto the market. Technology and the use of smart phones have opened the eyes of American healthcare consumers. A recent presentation by Dr. Francisco Velazquez, President and Chief Executive Officer of PAML, told the story of a quantified future in healthcare, where consumer technology is present in all areas of the spectrum. “The consumer driven technology enabled health and wellness market is currently over $500 Billion a year in the…

It’s the beginning of a New Year, and with it comes New Year’s resolutions to stay fit, happy, and healthy. Studies show organizations can be instrumental in employees keeping their wellness resolutions, while at the same time positively impacting business operations. The rise of wellness programs in the United States is prolific. Did you know that 92% of companies of 200 employees or more, implement a program with a health objective? Controlling rising healthcare costs due to chronic disease and obesity is reported as one of the top challenges companies face today. While wellness programs promote employees’ health, they are also…

Interview with Johannes Fruehauf, M.D., Ph.D. Co-Founder & President, LabCentral CEO, Biolabs, General Partner, BioInnovation Capital Fostering Biotechnology Innovation & Growth In this exclusive Slone Partners interview, Dr. Johannes Fruehauf shares the great success story behind LabCentral and its upcoming plan for expansion. He also discusses the wealth of life science talent in the Boston area and provides valuable insights on what he has learned as a biotech leader and entrepreneur. Slone Partners: What is the story behind LabCentral’s founding? Dr. Johannes Fruehauf: After we sold Cequent Pharmaceuticals in 2010, I was working on a new startup in the synthetic…

Interview with Andrew Fish, Executive Director, AdvaMedDx, and Chief Strategy Officer at AdvaMed. In this Slone Partners’ interview, we talk to Andy Fish about changes in the diagnostics industry and his forecast for the near future. Slone Partners: In your opinion, what is the most pressing issue in diagnostics in 2016/17? Andy Fish: Right now, regulation of laboratory developed tests, or LDTs, is a hot topic. Certainly, this is a priority issue for our industry, and AdvaMedDx has long advocated for the Food and Drug Administration to enforce its regulations with respect to LDTs, under a risk-based approach, to help…

Awards Golden Ticket to Auxocell Laboratories, Inc., an innovator in stem cell therapeutics and regenerative medicine CAMBRIDGE, Mass. – November 16, 2016 − Executive search firm Slone Partners is proud to contribute to the growth and development of the biotech and life sciences industries by sponsoring LabCentral, a first-of-its-kind shared laboratory space, which serves as a launchpad for high-potential startups. Founded in November 2013, LabCentral is a private, nonprofit organization providing a full range of services and programs to support the laboratory and business operations of early-stage companies. Located in the heart of the Cambridge biotech innovation hub, LabCentral offers laboratory and office space to as many…

Dr. Michael Dugan, veteran biotechnology executive, to lead company’s clinical advancement Executive recruitment firm Slone Partners is proud to announce the placement of Dr. Michael Dugan, an esteemed biotechnology leader with extensive clinical experience in both commercial and academic settings, as Chief Medical Officer of Clinical Genomics. Clinical Genomics is a leading biotechnology company that develops innovative products for colorectal cancer diagnosis. With a broad intellectual property portfolio including more than 20 patents, Clinical Genomics delivers products to improve early cancer detection. In his new role, Dr. Dugan will lead medical affairs and clinical trials, develop key opinion leader relationships, and build…

Personalized Medicine: A Payer’s Perspective To celebrate the highly anticipated 12th Annual Personalized Medicine Conference, Slone Partners offers a special PMC interview series featuring four key thought leaders. In the past few weeks, Slone Partners has shared with you insightful interviews with Dr. Stephen Eck, VP of Oncology Medical Sciences at Astellas Pharma Global Development, Dr. Amy Abernethy, CMO, CSO & SVP of Oncology at Flatiron Health & Dr. Michael Pellini, CEO at Foundation Medicine. To conclude this exclusive Personalized Medicine Conference series, Dr. Kristine Bordenave, Lead Medical Director at Humana shares her unique insights on the advancement of Personalized Medicine, the main roadblocks,…

Personalized Medicine: A Revolution in Our Mindset, Not in Technology On November 15th, industry leaders will gather in Boston for the much anticipated 12th Annual Personalized Medicine Conference. Leading up to the event, Slone Partners shares its special four-part PMC interview series. Our third interviewee, Dr. Michael Pellini, offers his unique perspective on the advancement of Personalized Medicine. In this exclusive interview, Dr. Pellini explains the importance of collaboration in the development of a regulatory framework, and the essential role of genomic profiling and data exchange in guiding the precision medicine approach. He also discusses how the Cancer Moonshot 2020 encourages…

Seasoned clinical laboratory executive to drive company’s growth Executive recruitment firm Slone Partners is pleased to announce the placement of Matthew Watson, an accomplished healthcare leader and entrepreneur with extensive clinical laboratory experience, as Chief Executive Officer of Westox Labs. Westox Labs is a fast-growing Southern California toxicology company offering a full line of superior laboratory-based and onsite drug testing solutions. Dedicated to providing first class service and support, the organization uses the most advanced laboratory technology paired with premier quality control mechanisms to ensure a high level of accuracy and consistency. In his new role, Mr. Watson will lead…

Renowned Oncologist & Cancer Data Researcher Walks You Through the Future of Big Data in Healthcare As part of our special PMC series, Slone Partners presents the unique perspective of four leaders driving progress in the personalized medicine space. Dr. Amy Abernethy, CMO, CSO & Senior VP of Oncology at Flatiron Health, is internationally recognized for accelerating cancer research through her distinctive outlook on data use in healthcare. In this exclusive interview, Amy outlines a path to solve the huge infrastructural challenge in healthcare data and discusses the importance of patient input in improving outcomes. Slone Partners: When approaching the use…

A View from Inside the Studies that Drive Personalized Medicine Leading up to the 12th Annual Personalized Medicine Conference this November, Slone Partners unveils a series of interviews with four key industry thought leaders. This exclusive PMC series will gather unique perspective on innovation in personalized medicine, clinical outcomes, and reimbursement decisions with a special focus on solutions. To set the stage, our first interviewee, Dr. Stephen L. Eck, discusses what he describes as life’s persistent questions as it pertains to diagnostics, drug development, and progress in the precision medicine space. Slone Partners: In a recent blog article, you discuss the…

Did you know that scientists have predicted that genomic data will soon overtake YouTube as the largest data pool in the world? San Diego is home to many of the fast-growing companies that will generate this abundance of data. To celebrate this accomplishment, the city establishing itself as the genomic tech capital of the world, will host one of the most interesting and highly attended genomics events. The Festival of Genomics California is a one-of-a-kind genomics meeting with “celeb-like” panel discussions, workshops, attractions, and over 85 hours of educational content. As one of the leading executive search firms in the genomics space,…

Driving Diagnostics Towards its Data-Centric Future “If the difference between evolution and revolution is the speed of change, then healthcare is now in the mode of revolutionary change.” Internationally renowned as a leading figure of the life sciences, healthcare & healthcare IT industries, Harry Glorikian is a company founder, sought-after speaker, and author of numerous publications distributed worldwide. In this exclusive Slone Partners interview, Harry opens up about his new diagnostics book coming out this fall, the biggest challenges & trends facing the IVD industry, and the most pressing healthcare issues of our time and why they must be overcome….

Adam Slone, founder of Slone Partners, has overseen the recruitment of thousands of professionals into the medical diagnostics and laboratory testing industries since the company’s creation in 2000. This summer Adam launched a brand new recruitment effort, the country’s first sleepaway tennis camp for underserved youth. Life Serve Youth Foundation, a nonprofit organization based in New York City, offers the first overnight tennis camp in the United States that provides exceptional training and personal development opportunities for youth with limited financial resources. The foundation offers a free 14-day overnight tennis camp for kids 12 to 17 with a demonstrated potential…

August 23-26, 2016, the Next Generation Dx Summit will bring together more than 1,000 international diagnostic professionals to exchange key insights on a wide range of topics including NGS data considerations and interpretation, cell-free DNA, immunotherapy biomarkers, coverage and reimbursement, business strategy, and much more. As a long time sponsor of the summit, Slone Partners is proud to support leaders and contribute to the success of organizations in the diagnostics space who are shaping the future of healthcare. This year, the Next Generation Dx Summit has an incredible list of panel discussions, breakout sessions and symposia covering the diagnostics space….

Executive recruitment firm Slone Partners is pleased to announce its co-sponsorship of the first-of-its-kind Precision Medicine Leaders Summit in San Diego, California. This conference is designed to discuss the frontier of Precision Medicine and its implementation into global healthcare systems. Speakers at the conference will include CEOs, industry thought leaders, White House officials, and Hollywood actors, among others. As specialists in the industries that are central to Precision Medicine, Slone Partners’ active participation in the summit supports leaders that are catalyzing change in the healthcare space as they look to hire talent and grow their organizations. The first Precision Medicine Leaders Summit brings together…

Leading 3,200 employees in the ever-changing diagnostics industry “One of the best attributes that a leader can develop is the ability to choose the right person for the right job at the right time,” says Dave Dexter, CEO of Sonora Quest Laboratories. With 16 years as the leader of a company with over 3,200 employees, Dave Dexter’s advice on leadership and building a high performance team is some of the best in the business. In this exclusive Slone Partners interview, he discusses the importance of work-life balance, how to communicate your company culture at all levels, and why perspective is…

Executive recruitment firm Slone Partners has named Leslie Loveless to the position of Chief Executive Officer, effective immediately. She succeeds Adam Slone, who founded the firm in 2000. “Slone Partners has built a tradition of quality and service excellence that is the hallmark of our business. It’s an honor to lead this organization and to carry on our mission to deliver the best leaders to build amazing organizations,” Leslie said. Leslie joined Slone Partners in 2007 and was promoted to Chief Operating Officer in 2014. She brings more than 17 years of healthcare sales, training, and recruiting experience to the firm….

Suzanne Hill, life sciences executive, to lead the North American sales team in the commercialization of the HTG EdgeSeq system for HTG Molecular. National recruitment firm Slone Partners is pleased to announce the placement of Suzanne Hill, a life sciences executive with extensive sequencing and genomics experience, as Vice President of North American Capital Sales at HTG Molecular. In this position, Ms. Hill will be responsible for leading the sales team in the commercialization of the HTG EdgeSeq system and associated reagents in North America. Headquartered in Tucson, Arizona, HTG’s mission is to empower precision medicine at the local level. In 2013, the…

Slone Partners is active in the Clinical Trials / CRO space, providing counsel and delivering premier talent to the industry’s most innovative organizations. To stay on top of new market opportunities, trends, and challenges, we will attend the DIA conference this month. DIA 2016, the largest global interdisciplinary health care event in the nation, will bring together over 7,000 thought leaders and innovators from the life sciences industry, academia, and government agencies. The DIA Conference has an incredible list of talks, tutorials, and networking sessions covering the clinical trials and CRO space. With so many valuable topics to choose from, we…

The clinical trials ecosystem is undergoing an evolution.The demand for clinical trials is higher than ever before, and the trials are becoming more targeted and complex. Methods for engaging patients are moving towards digital platforms, often through apps. Today, outsourcing to a new breed of Clinical Research Organizations (CROs) is increasingly becoming the cornerstone of many business strategies. Focused on this growing space, the upcoming DIA 2016 Conference (Develop, Innovate, Advance) will be the largest global interdisciplinary health care event in the nation. It brings together over 7,000 global thought leaders and innovators from the life sciences industry, academia, and…

Securing the best talent in the diagnostics, precision medicine and life science space After the success of Becoming CEO, Slone Partners launches its Leadership series, in which industry leaders share their views on building successful organizations and high-performance teams. To set the stage, our first interviewee is our Slone Partners Chief Executive Officer Adam Slone. What prompted you to start Slone Partners back in 2000? Adam Slone: I come from a very entrepreneurial family. My father, mother, and brother each operated businesses. My brother still has his business and it is quite large. I had no interest in business for…

Funding America’s Next Generation of Healthcare Leaders With healthcare reform and technology innovation forces reshaping the healthcare industry, there is opportunity abound, and organizations with the right leaders have everything to gain from an infusion of capital and the counsel of experienced board members. While working for Highland Capital Partners, Bijan Salehizadeh discovered a passion for helping founders of healthcare companies who are ready to transition to the next phase of growth. Inspired by his mentors Bob Higgins and Paul Maeder, who had founded that firm in 1988, he pursued this passion and raised a fund for NaviMed Capital, a…

National recruitment firm Slone Partners announces its 10th consecutive year as a key contributor to the pre-eminent laboratory and pathology conference. Executive recruitment firm Slone Partners announces its contribution as a corporate benefactor of the 21st Executive War College on Laboratory and Pathology Management, the annual conference gathering of the nation’s pre-eminent laboratory leaders and pathology experts. As specialists in the diagnostics, life science tools, healthcare information technology and laboratory testing industries, Slone Partners attendance at the event is in support of the nation’s diagnostic laboratories, which continue to pioneer scientific innovations in the most difficult regulatory environment they have faced. “The diagnostics…

National recruitment firm Slone Partners is pleased to announce it will be a corporate sponsor for the 23rd International Molecular Med TRI-CON, the largest annual networking event attended by the world’s most influential diagnostics experts. As a specialty recruitment firm for the diagnostics, life science tools, healthcare information technology and laboratory testing industries, Slone Partners contributes to the advancement of the diagnostics space by developing, for its clients, teams who are composed of amazing talent. “The genomics space is showing tremendous growth and, as a result, competition for talent has greatly increased. For companies who are developing a team in…

Using Big Data to Drive Precision Medicine Located in the heart of Cambridge, Mass., Genospace is a fast-growing cloud-based software company whose mission is to harness data to pioneer solutions in precision medicine. “The world is awash with genomic data,” says Mick Correll, the company’s CEO. Currently, the volume of genomic data collected is experiencing exponential growth, doubling every seven months, and by 2025, scientists predict approximately 1 billion people will have their genomes sequenced. This pace of growth makes data storage a priority in the genomics space, and makes data analysis the best opportunity to translate this resource into…

On Becoming CEO leaders in the cutting-edge diagnostics space share how their careers developed and the goals and aspirations that motivate them. Andy Fish is the Executive Director of AdvaMedDx, an organization that advocates for the power of medical diagnostic tests to promote wellness, improve patient outcomes, and advance public health in the United States and abroad. His advocacy organization represents over 75 member companies that produce innovative diagnostic tests performed in laboratories, at the hospital bedside, in doctor’s offices, in medical clinics, and in the home. These tests facilitate evidence-based medicine, improve quality of care, promote wellness, and enable early…

National recruitment firm Slone Partners is pleased to announce the placement of Mrs. Nadia Altomare as President of North America at Abcodia, a specialist company engaged in the development of tests for early detection of cancer. Executive recruitment firm Slone Partners is pleased to announce the placement of Mrs. Nadia Altomare as President of North America at Abcodia, a specialist company engaged in the development of tests for early detection of cancer. In this position, Mrs. Altomare will develop and implement the strategic business plan for the US operations, launch the company’s first early cancer detection product, the ROCA® test in the US,…